<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6566568</article-id><article-id pub-id-type="doi">10.3390/nu11051179</article-id><article-id pub-id-type="publisher-id">nutrients-11-01179</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Overcoming the Bitter Taste of Oils Enriched in Fatty Acids to Obtain Their Effects on the Heart in Health and Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Stamenkovic</surname><given-names>Aleksandra</given-names></name><xref ref-type="aff" rid="af1-nutrients-11-01179">1</xref><xref ref-type="aff" rid="af2-nutrients-11-01179">2</xref></contrib><contrib contrib-type="author"><name><surname>Ganguly</surname><given-names>Riya</given-names></name><xref ref-type="aff" rid="af1-nutrients-11-01179">1</xref><xref ref-type="aff" rid="af2-nutrients-11-01179">2</xref></contrib><contrib contrib-type="author"><name><surname>Aliani</surname><given-names>Michel</given-names></name><xref ref-type="aff" rid="af3-nutrients-11-01179">3</xref><xref ref-type="aff" rid="af4-nutrients-11-01179">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6663-1225</contrib-id><name><surname>Ravandi</surname><given-names>Amir</given-names></name><xref ref-type="aff" rid="af1-nutrients-11-01179">1</xref><xref ref-type="aff" rid="af2-nutrients-11-01179">2</xref><xref ref-type="aff" rid="af5-nutrients-11-01179">5</xref></contrib><contrib contrib-type="author"><name><surname>Pierce</surname><given-names>Grant N.</given-names></name><xref ref-type="aff" rid="af1-nutrients-11-01179">1</xref><xref ref-type="aff" rid="af2-nutrients-11-01179">2</xref><xref ref-type="aff" rid="af3-nutrients-11-01179">3</xref><xref rid="c1-nutrients-11-01179" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-11-01179"><label>1</label>Institute of Cardiovascular Sciences, St Boniface Hospital, Winnipeg, MB R2H2A6, Canada; <email>astamenkovic@sbrc.ca</email> (A.S.); <email>gangulr@gmail.com</email> (R.G.); <email>aravandi@sbgh.mb.ca</email> (A.R.)</aff><aff id="af2-nutrients-11-01179"><label>2</label>Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E0W3, Canada</aff><aff id="af3-nutrients-11-01179"><label>3</label>Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), Albrechtsen Research Centre, St Boniface Hospital, University of Manitoba, Winnipeg, MB R2H2A6, Canada; <email>maliani@sbrc.ca</email></aff><aff id="af4-nutrients-11-01179"><label>4</label>Department of Human Nutritional Sciences, Faculty of Agricultural and Food Sciences, University of Manitoba, Winnipeg, MB R2H2A6, Canada</aff><aff id="af5-nutrients-11-01179"><label>5</label>Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E0W3, Canada</aff><author-notes><corresp id="c1-nutrients-11-01179"><label>*</label>Correspondence: <email>gpierce@sbrc.ca</email>; Tel.: +1-204-235-3206; Fax: +1-204-235-0793</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2019</year></pub-date><volume>11</volume><issue>5</issue><elocation-id>1179</elocation-id><history><date date-type="received"><day>16</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Fatty acids come in a variety of structures and, because of this, create a variety of functions for these lipids. Some fatty acids have a role to play in energy metabolism, some help in lipid storage, cell structure, the physical state of the lipid, and even in food stability. Fatty acid metabolism plays a particularly important role in meeting the energy demands of the heart. It is the primary source of myocardial energy in control conditions. Its role changes dramatically in disease states in the heart, but the pathologic role these fatty acids play depends upon the type of cardiovascular disease and the type of fatty acid. However, no matter how good a food is for one&#x02019;s health, its taste will ultimately become a deciding factor in its influence on human health. No food will provide health benefits if it is not ingested. This review discusses the taste characteristics of culinary oils that contain fatty acids and how these fatty acids affect the performance of the heart during healthy and diseased conditions. The contrasting contributions that different fatty acid molecules have in either promoting cardiac pathologies or protecting the heart from cardiovascular disease is also highlighted in this article.</p></abstract><kwd-group><kwd>bitter taste</kwd><kwd>fatty acids</kwd><kwd>heart disease</kwd><kwd>metabolism</kwd><kwd>atherosclerosis</kwd><kwd>ischemia</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-11-01179"><title>1. The Challenge of Incorporating Fatty Acid into the Diet</title><p>Dietary intake of fatty acids is important for human and animal health. Indeed, this is particularly clear with essential fatty acids which are not found in the body and must be ingested to be present. Essential fatty acids like alpha-linolenic acid (ALA), an omega-3 fatty acid, and linoleic acid (LA), an omega-6 fatty acid, are necessary for human health. However, despite the requirement for these fatty acids in human health, the acceptability of oils that contain fatty acids in the diet is a significant challenge due to their taste characteristics. This can be compounded by limited shelf stability of oils that may compromise taste and aroma further through unwanted oxidation of the fatty acids found in the oil. </p><p>Analytical methods used for studying the compounds that cause bitterness in food include chromatography and mass spectrometry, but also sensory evaluation. The so-called &#x0201c;electronic tongue&#x0201d; is a simple device used to analyze the compounds in food using chemical sensors in a similar way as the human tongue analyses taste. Busch et al. validated the efficacy of the electronic tongue in detecting bitterness in virgin olive oils by conducting a study in which they compared the enzyme-based biosensors and a standard HPLC method for the analyses of the total content of phenolics in virgin olive oils [<xref rid="B1-nutrients-11-01179" ref-type="bibr">1</xref>].</p><p>Olive oil and flaxseed oil (also known as linseed oil) are two commonly used culinary oils. Both oils exhibit a bitter and pungent taste [<xref rid="B2-nutrients-11-01179" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-11-01179" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-11-01179" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-11-01179" ref-type="bibr">5</xref>,<xref rid="B6-nutrients-11-01179" ref-type="bibr">6</xref>]. This can limit their acceptance in the general population and restrict their use in both regular diets and in experimental research studies as well [<xref rid="B7-nutrients-11-01179" ref-type="bibr">7</xref>]. Different agricultural practices, new processing technologies, and educational campaigns to emphasize the benefits of an association of a bitter taste with health have all been suggested as strategies to improve the acceptance of these oils in the general population [<xref rid="B3-nutrients-11-01179" ref-type="bibr">3</xref>]. However, the acceptance of the bitterness in oil is influenced by the country of origin of the consumer. Spanish consumers were more tolerant of the pungent and bitter taste characteristics of olive oil than were their American counterparts [<xref rid="B6-nutrients-11-01179" ref-type="bibr">6</xref>]. The bitter taste originates from the unique polar polyphenol-rich composition of the oils [<xref rid="B3-nutrients-11-01179" ref-type="bibr">3</xref>]. Extended storage of flaxseed oil can result in its deterioration and generation of methionine oxidation of its cyclolinopeptides [<xref rid="B2-nutrients-11-01179" ref-type="bibr">2</xref>]. The primary one responsible for the bitter taste of flaxseed oil has been identified as cyclic octapeptide cyclo (PLFIM OLVF) [<xref rid="B5-nutrients-11-01179" ref-type="bibr">5</xref>], also referred to as cyclolinopeptide E [<xref rid="B2-nutrients-11-01179" ref-type="bibr">2</xref>].</p><p>The bitter taste can be reduced in a variety of ways. From a food processing standpoint, both high and low temperatures can be used as effective ways of reducing the bitter taste. Storage of olive oil at 5 &#x000b0;C for two to eight weeks leads to a reduction in bitterness [<xref rid="B8-nutrients-11-01179" ref-type="bibr">8</xref>]. In addition, Garcia et al. showed that heating the olives leads to a decrease in olive oil bitterness and the reduction in bitterness correlated with the time and temperature used for heating [<xref rid="B9-nutrients-11-01179" ref-type="bibr">9</xref>]. Heating the olives did not cause any changes in the oxidative stability of the olive oil or its acidity, however, Garcia et al. did find decreased levels of phenolic content. Not only heat, but also cold temperatures can be effective in reducing the bitterness of olive oil. Another method used successfully to reduce the bitterness of olive oil is the addition of phospholipids. Koprivnjak et al. [<xref rid="B10-nutrients-11-01179" ref-type="bibr">10</xref>] showed that the addition of 5&#x02013;10 g of soy lecithin/kg olive oil leads to a significant reduction in bitterness and an increase in the sweetness of olive oil. The partitioning of polyphenols between oil and water phases can be an effective method used to decrease the total polyphenol content and therefore leads to a reduction in bitterness without affecting the physicochemical parameters of oil [<xref rid="B11-nutrients-11-01179" ref-type="bibr">11</xref>]. Adding spices [<xref rid="B4-nutrients-11-01179" ref-type="bibr">4</xref>] or flavorings to the oils can also change the taste characteristics in a way to try to make the oil more compatible. Shape Foods, Inc. in Brandon. Manitoba Canada produced a variety of flavored flax oils in dessert flavors (chocolate, caramel, banana, and coconut) and culinary flavors (Italian, Mexican, Indian, Thai, Szechuan and Culinary).</p><p>Fish, hempseed, flaxseed, and olive oil can be ingested as an oil by the spoonful, in salad dressings, by pill form or incorporated into food products [<xref rid="B7-nutrients-11-01179" ref-type="bibr">7</xref>,<xref rid="B12-nutrients-11-01179" ref-type="bibr">12</xref>,<xref rid="B13-nutrients-11-01179" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-11-01179" ref-type="bibr">14</xref>]. The oils provide the fatty acids to the body with greater bioavailability than foods that contain the same amount of fatty acids [<xref rid="B13-nutrients-11-01179" ref-type="bibr">13</xref>]. However, each of these types of oils (i.e., fish versus hemp versus flax) has a different bioavailability to the body [<xref rid="B14-nutrients-11-01179" ref-type="bibr">14</xref>]. Fish oil had its eicosapentaenoic acid (EPA)/docosahexanoeic acid (DHA) content absorbed better than the ALA in flaxseed oil, which was more bioavailable than the LA in hempseed oil [<xref rid="B14-nutrients-11-01179" ref-type="bibr">14</xref>]. However, although the bioavailability and the biological benefit of each of these fatty acids differ considerably, encouraging the consuming public to actually ingest these oils has been a considerable challenge. The incorporation of these fatty acids into foods commonly consumed disguises their bitter taste characteristics and encourages greater acceptability [<xref rid="B7-nutrients-11-01179" ref-type="bibr">7</xref>,<xref rid="B12-nutrients-11-01179" ref-type="bibr">12</xref>]. For example, even though bioavailability may be compromised slightly [<xref rid="B13-nutrients-11-01179" ref-type="bibr">13</xref>], the inclusion of milled flaxseed into biscuits, muffins, bagels, bread products, and even pasta can increase consumption [<xref rid="B13-nutrients-11-01179" ref-type="bibr">13</xref>]. In 2011, Aliani and colleagues used a trained sensory panel to test whether adding different flavors will reduce the bitterness of muffins and snack bars containing milled flaxseed [<xref rid="B7-nutrients-11-01179" ref-type="bibr">7</xref>]. Flaxseed is rich in the omega-3 fatty acid ALA. Among several flavors used such as apple spice, gingerbread raisin, orange cranberry, and cappuccino chocolate, the gingerbread raisin flavor reduced the bitterness of flax best. Therefore, the authors suggested that the flavorings that naturally contain a small amount of bitterness could be effective in reducing the bitterness caused by flax [<xref rid="B7-nutrients-11-01179" ref-type="bibr">7</xref>].</p><p>The food processing industry is beginning to recognize this potential and is starting to incorporate healthy fatty acids into foods without compromising taste. Ultimately, this will introduce these beneficial fatty acids into the daily diet of the general public to allow them to access their heart-health benefits.</p></sec><sec sec-type="intro" id="sec2-nutrients-11-01179"><title>2. Introduction to the Biological Activity of Fatty Acids </title><p>Fatty acids play a role in energy generation and storage, phospholipid membrane formation, and signaling pathways. Therefore, fatty acid metabolism can be catabolic with respect to energy and metabolite generation or anabolic for creating biologically important molecules from dietary sources of fatty acids.</p><p>Fatty acid metabolism plays a particularly important role in the heart. The continuous pumping action of the heart exhibits a high energy demand. ATP is the ultimate source of this energy. In order to generate ATP at a high enough rate to sustain cardiac contractility, almost all ATP (&#x02212;95%) is derived from mitochondrial oxidative phosphorylation [<xref rid="B15-nutrients-11-01179" ref-type="bibr">15</xref>]. The remainder is derived from glycolysis within the tricarboxylic acid (TCA) cycle. Beta oxidation within the heart is under complex control. The factors which affect the cycle include the supply of fatty acid, the presence of competing substrates, the energy demand of the heart and the supply of oxygen to the heart [<xref rid="B15-nutrients-11-01179" ref-type="bibr">15</xref>]. Fatty acids can be recognized by the heart as free fatty acids (FFA), triacylglycerol (TAG), or very low-density lipoproteins (VLDL). In the case of VLDL, the enzyme lipoprotein lipase (LPL) can hydrolyze TAG and VLDL within cardiomyocytes. Regulation of LPL plays a significant role in fatty acid metabolism within the heart. Increased LPL translocation to the plasma membrane has been correlated with increased beta oxidation [<xref rid="B16-nutrients-11-01179" ref-type="bibr">16</xref>]. Mitochondrial uptake of fatty acids is regulated by carnitine palmitoyltransferase (CPT1). The enzyme CPT1 catalyzes and converts long-chain acyl-CoA into long-chain acyl-carnitine. This facilitates uptake into the mitochondria and will have distinct effects on rates of beta oxidation. Changes in fatty acid metabolism within the heart have been implicated in a variety of complex cardiovascular diseases.</p><p>Once fatty acids are taken up by the cell through transport proteins and/or passive diffusion, they can then be converted into energy. This process is known as beta oxidation. Once the fatty acid is taken up within the cell, a CoA group is added to the fatty acid using the enzyme fatty acid CoA synthase (FACS). This forms long-chain acyl-CoA. Carnitine palmitoyltransferase 1 (CPT1) converts long-chain acyl-CoA to long-chain acylcarnitine. This allows the fatty acid moiety to be transported into the inner mitochondrial membrane via carnitine translocase. The inner membrane protein CPT2 then converts long-chain acylcarnitine back to long-chain acyl-CoA inside the mitochondria. The long-chain acyl-CoA then enters the beta oxidation pathway. Fatty acid beta oxidation consists of breaking down the long-chain acyl-CoA molecule into acetyl-CoA. Four main enzymes are used in the process to convert acyl-CoA to acetyl-CoA. The number of acetyl-CoA molecules is dependent upon the carbon chain length in the fatty acid. Acetyl-CoA can then enter the citric acid cycle and electron transport chain to yield ATP [<xref rid="B15-nutrients-11-01179" ref-type="bibr">15</xref>].</p><p>Other than beta oxidation, fatty acids can also be used in other key processes within the cell. Of note, polyunsaturated fatty acids (PUFAs) are integrated into phospholipids within the cell membrane. Structurally, phospholipids (or glycerophospholipids) consist of a glycerol backbone, two fatty acids and a phosphate containing a polar head group. PUFAs are preferentially incorporated into the sn-2 position of phospholipids. Incorporation of omega-3 PUFAs into membrane phospholipids can lead to changes in membrane properties and alter the function of membrane proteins [<xref rid="B17-nutrients-11-01179" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-11-01179" ref-type="bibr">18</xref>]. It has been shown that the antiarrhythmic effect of omega-3 PUFAs is achieved by their incorporation into membranes and modulation of ion channel function in cardiomyocytes [<xref rid="B19-nutrients-11-01179" ref-type="bibr">19</xref>]. </p><p>On demand, specific PUFAs can be cleaved from the phospholipid by phospholipase A<sub>2</sub> (PLA<sub>2</sub>) [<xref rid="B20-nutrients-11-01179" ref-type="bibr">20</xref>]. Once cleaved, PUFAs can undergo enzymatic oxygenation and are transformed into short term lipid mediators known as oxylipins [<xref rid="B20-nutrients-11-01179" ref-type="bibr">20</xref>]. Moreover, PUFAs on the sn-2 position of phospholipids can be oxidized leading to the production of oxidized phospholipids which were recently shown to be involved in the formation and progression of various cardiovascular pathologies [<xref rid="B20-nutrients-11-01179" ref-type="bibr">20</xref>,<xref rid="B21-nutrients-11-01179" ref-type="bibr">21</xref>,<xref rid="B22-nutrients-11-01179" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-11-01179" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-11-01179" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-11-01179" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-11-01179" ref-type="bibr">26</xref>].</p><p>Oxylipins represent a class of fatty acid metabolites present in all tissues in the body and produced by oxygenation of polyunsaturated fatty acids by three different enzymes. The tissue oxylipin profile depends on many different factors. Since oxylipins are derived from polyunsaturated fatty acids, the amount of dietary PUFAs influences oxylipin production. Moreover, the presence of different enzymes, as well as enzyme preferences for certain PUFAs, will influence the tissue oxylipin profile. The major, but not the only source of oxylipins, are fatty acids released from membrane phospholipids by the cytosolic PLA<sub>2</sub> [<xref rid="B27-nutrients-11-01179" ref-type="bibr">27</xref>]. Upon releasing fatty acids from the phospholipids, these fatty acids are converted to oxylipins by three main pathways: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 (CYP) epoxygenase and omega-hydrolase [<xref rid="B28-nutrients-11-01179" ref-type="bibr">28</xref>].</p></sec><sec id="sec3-nutrients-11-01179"><title>3. Dietary Fatty Acids and Cardiovascular Disease</title><p>There has been a great deal of interest in two distinct categories of PUFAs on cardiovascular disease, the <italic>n</italic>-6 and <italic>n</italic>-3 fatty acids [<xref rid="B29-nutrients-11-01179" ref-type="bibr">29</xref>]. The position of the double bond, either in the 3rd or 6th position from the methyl end group will distinguish an <italic>n</italic>-6 fatty acid from an <italic>n</italic>-3 fatty acid. Within the cell, these &#x02018;essential&#x02019; fatty acids are metabolized and converted into physiologically recognized compounds [<xref rid="B30-nutrients-11-01179" ref-type="bibr">30</xref>]. Long-chain <italic>n</italic>-3 fatty acids like ALA can be converted into two longer chain derivatives (DHA-docosahexaenoic acid and EPA-eicosatetraenoic acid), primarily by the 5- and 6-desaturase enzymes (<xref ref-type="fig" rid="nutrients-11-01179-f0A1">Figure A1</xref>). DHA is derived from EPA by <italic>&#x003b2;</italic>-oxidation. <italic>n</italic>-6 fatty acids such as linoleic acid (LA) are converted into AA using the 5- and 6-desaturases similar to <italic>n</italic>-3 fatty acids. A higher ratio of <italic>n</italic>-6: <italic>n</italic>-3 intake in the diet will shift the desaturase action to favor the production of AA [<xref rid="B30-nutrients-11-01179" ref-type="bibr">30</xref>].</p><p>Essential fatty acids can only be found in dietary sources and are required for adequate function of the human body. Essential fatty acids cannot be made by the human body. It is important to note that there are two major sources of essential fatty acids: alpha-linolenic acid (ALA) and linoleic acid (LA). ALA is an <italic>n</italic>-3 PUFA found in a variety of food items such as walnuts and flaxseeds. However, it is most prevalent in flaxseed. LA is an <italic>n</italic>-6 PUFA enriched in safflower, poppyseed and rapeseed oil [<xref rid="B31-nutrients-11-01179" ref-type="bibr">31</xref>]. These two fatty acids serve in a variety of cell maintenance functions. There is evidence, however, suggesting that over-consumption of <italic>n</italic>-6 PUFAs may lead to increased inflammation within the body. It is important to note that fatty acids (essential or nonessential) can be found in a variety of dietary sources. Depending upon the saturation, different fatty acids are found in different foods. PUFAs are generally found in fish, flaxseed and grape seed oils. Saturated fatty acids (SFAs) are found in palm, coconut and cottonseed oils as well as chocolate products [<xref rid="B32-nutrients-11-01179" ref-type="bibr">32</xref>]. Further research into some of these fatty acids to better elucidate their effects within the body and more specifically, their mechanism of action, will aid in the ongoing research within the field of nutraceuticals and functional foods [<xref rid="B33-nutrients-11-01179" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-11-01179" ref-type="bibr">34</xref>,<xref rid="B35-nutrients-11-01179" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-11-01179" ref-type="bibr">36</xref>,<xref rid="B37-nutrients-11-01179" ref-type="bibr">37</xref>].</p><p>Unlike <italic>n</italic>-6 fatty acids, <italic>n</italic>-9 fatty acids are primarily found in foods such as olive oil, rapeseed oil, mustard seeds/oil, and wallflower seeds. Omega-9 fatty acids are usually found in two forms, oleic acid (18:1 <italic>n</italic>-9) and erucic acid (22:1 <italic>n</italic>-9). Both of these fatty acids have important biological functions. For example, oleic acid, found in olive oil, has been shown to decrease inflammation [<xref rid="B32-nutrients-11-01179" ref-type="bibr">32</xref>]. Erucic acid is enriched in colewort or kale. Some of the early studies suggested no severe effects of erucic acid on the heart [<xref rid="B38-nutrients-11-01179" ref-type="bibr">38</xref>], however, more recent evidence has correlated high intake of erucic acid with complications within the heart [<xref rid="B39-nutrients-11-01179" ref-type="bibr">39</xref>]. Therefore, erucic acid intake should be limited to 2% of total energy intake [<xref rid="B40-nutrients-11-01179" ref-type="bibr">40</xref>].</p><p>Dietary fat recommendations for cardiovascular health have focused on limiting the intake of saturated fatty acids. Studies of the association between saturated fatty acid intake and cardiovascular disease has generated conflicting data, with some dietary guidelines recommending to limit SFA intake and other studies showing no connection between SFA and CVD. A meta-analysis of 21 cohort studies showed no association between SFA consumption and an increased risk of CVD and coronary heart disease (CHD) [<xref rid="B41-nutrients-11-01179" ref-type="bibr">41</xref>]. However, the key to cardiovascular health may be the type of nutrient that replaces SFAs. An analysis of 11 cohort studies showed that the replacement of 5% energy intake of SFAs with PUFAs was associated with decreased risk of coronary events and mortality [<xref rid="B42-nutrients-11-01179" ref-type="bibr">42</xref>]. Another two prospective cohort studies reported a 25% and 15% reduction in CVD risk when SFAs are replaced with PUFAs and monounsaturated fatty acids (MUFAs), respectively [<xref rid="B43-nutrients-11-01179" ref-type="bibr">43</xref>]. Conversely, the replacement of SFAs with carbohydrates augmented the risk of coronary events [<xref rid="B42-nutrients-11-01179" ref-type="bibr">42</xref>].</p><p>Omega-3 fatty acids are found in a variety of sources. Marine oils contain two major <italic>n</italic>-3 fatty acids. EPA and DHA have important anti-inflammatory and early developmental functions within the body [<xref rid="B44-nutrients-11-01179" ref-type="bibr">44</xref>]. Unlike ALA, DHA and EPA can be derived within the body through different enzymes known as desaturases. ALA is an essential fatty acid and can be a precursor for DHA and EPA. However, ALA is not completely converted to both EPA and DHA. ALA is a plant-derived <italic>n</italic>-3 PUFA and can be found in walnuts, sunflower seed, and flaxseed. ALA has important biological actions within the heart [<xref rid="B35-nutrients-11-01179" ref-type="bibr">35</xref>,<xref rid="B45-nutrients-11-01179" ref-type="bibr">45</xref>]. In the National Heart, Lung and Blood Institute (NHLBI) study, it was demonstrated that LA and ALA decrease the risk of heart disease by 40% and 70%, respectively [<xref rid="B46-nutrients-11-01179" ref-type="bibr">46</xref>].</p><p>Trans fatty acids (TFAs) are unsaturated fatty acids in which the double bond is in the trans configuration. Artificial TFAs are produced during industrial hydrogenation of vegetable oils leading to solidification and an increase in the half-life for the purpose of prolonged storage in the food industry. Natural TFAs are produced in the rumen of ruminants as a product of bacterial transformation and are found in small amounts in dairy and meat products [<xref rid="B47-nutrients-11-01179" ref-type="bibr">47</xref>]. The most common industrial TFA is elaidic acid (18:1, omega-9), while vaccenic acid (18:1, omega-7) represents the major ruminant TFA [<xref rid="B48-nutrients-11-01179" ref-type="bibr">48</xref>]. According to the current guidelines of the European Food Safety Authority, TFA intake should be &#x0003c;1% of the total caloric intake. North Americans consume between 5&#x02013;10 g/day of industrial TFAs daily which constitutes approximately 2&#x02013;5% of total energy within our diets [<xref rid="B34-nutrients-11-01179" ref-type="bibr">34</xref>]. However, some studies suggest that some individuals consume up to 20 g/day of industrial TFAs [<xref rid="B49-nutrients-11-01179" ref-type="bibr">49</xref>,<xref rid="B50-nutrients-11-01179" ref-type="bibr">50</xref>]. A 2% increase in TFA consumption leads to a 23% increase in the risk of CHD [<xref rid="B51-nutrients-11-01179" ref-type="bibr">51</xref>]. TFAs have been associated with an increased risk of CVD by altering serum lipid composition. They increase the ratio of total cholesterol to high-density lipoprotein cholesterol which is an important predictor of CVD [<xref rid="B52-nutrients-11-01179" ref-type="bibr">52</xref>]. In addition, they increase the levels of low-density lipoprotein (LDL) cholesterol and reduce the levels of high-density lipoprotein cholesterol [<xref rid="B52-nutrients-11-01179" ref-type="bibr">52</xref>], triglyceride levels [<xref rid="B53-nutrients-11-01179" ref-type="bibr">53</xref>], and increase Lp(a) levels [<xref rid="B54-nutrients-11-01179" ref-type="bibr">54</xref>]. Increased dietary TFA intake induces inflammation in women as confirmed by increased levels of interleukin-6 and C- reactive protein [<xref rid="B55-nutrients-11-01179" ref-type="bibr">55</xref>]. Therefore, the effect on CVD can be indirect, since inflammation is an independent risk factor for atherosclerosis [<xref rid="B56-nutrients-11-01179" ref-type="bibr">56</xref>]. Furthermore, there is evidence that increased TFA intake leads to endothelial dysfunction by increasing the levels of intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1, and E-selectin [<xref rid="B57-nutrients-11-01179" ref-type="bibr">57</xref>]. Apart from playing a role in the development of atherosclerosis, TFA can have an influence on atherosclerotic plaque stabilization. The type of atheromatous plaque with a thin &#x0003c;65 &#x000b5;m fibrous cap which is infiltrated by macrophages [<xref rid="B58-nutrients-11-01179" ref-type="bibr">58</xref>] is most prone to rupture [<xref rid="B59-nutrients-11-01179" ref-type="bibr">59</xref>]. In a cross-sectional study of the association between TFAs and a thin fibrous cap atheroma as assessed by optical computed tomography, an association was identified between serum levels of elaidic acid and the presence of a thin fibrous cap atheroma in patients with CHD [<xref rid="B60-nutrients-11-01179" ref-type="bibr">60</xref>].</p><p>In addition to simply avoiding the ingestion of TFAs, nutritional interventions can be an effective way of altering the deleterious effects of trans fatty acids on atherosclerosis development. In a mouse model of atherosclerosis, intake of ground flaxseed, or an ALA-rich flaxseed oil prevented atherosclerotic plaque development induced by mild or moderate TFA intake [<xref rid="B35-nutrients-11-01179" ref-type="bibr">35</xref>].</p></sec><sec id="sec4-nutrients-11-01179"><title>4. Polyunsaturated Fatty Acids in Atherosclerosis</title><p>Atherosclerosis is a chronic disease characterized by lipid deposition and inflammation and hardening of the arteries. An atherosclerotic plaque can be asymptomatic or, as it progresses, it can become unstable, or it can rupture leading to myocardial infarction. Fatty acids are involved in plaque formation and stabilization. Dietary fatty acids can affect atherosclerosis in both a negative or a positive way depending on their structure. In a study conducted in 111 patients with CAD, fatty acid profiles established by gas chromatography showed significant correlation between trans fatty acids: elaidic acid (C18:1trans 9), trans isomers of linoleic acid (trans C18:2 isomers) and trans 11 eicosanoic acid (C20:1 trans 11) and biomarkers of oxidative stress, inflammatory parameters (hs-CRP, IL-6, TNF&#x02013;&#x003b1;) as well as vascular severity [<xref rid="B38-nutrients-11-01179" ref-type="bibr">38</xref>]. Increased trans fatty acid intake correlates with an increase in LDL, leading to a promotion of atherosclerosis [<xref rid="B61-nutrients-11-01179" ref-type="bibr">61</xref>]. An association between saturated fatty acid intake and CVD has been extensively studied. The first trial known as the &#x0201c;Seven Countries Study&#x0201d; had more than 12.000 participants within the seven countries: United States, Finland, Italy, Yugoslavia, Greece, Japan, and the Netherlands. It showed that saturated fatty acids are the most powerful lifestyle predictor of CVD [<xref rid="B62-nutrients-11-01179" ref-type="bibr">62</xref>]. However, the most recent study that enrolled &#x0003e;135,000 patients, aged 35&#x02013;70 years in the 18 countries, with over seven years follow-up showed that increased SFA intake was not associated with major CVD outcomes [<xref rid="B63-nutrients-11-01179" ref-type="bibr">63</xref>].</p><p>Omega-6 and omega-3 fatty acids play an important role in cardiovascular disease and health. Conversion of omega-6 fatty acids like LA to arachidonic acid and the conversion of omega-3 fatty acids to DHA and EPA is a process driven by the same enzymes. Therefore, the conversion of ALA will depend on the amount of ALA and LA ingested, but not their ratio [<xref rid="B64-nutrients-11-01179" ref-type="bibr">64</xref>]. While LA is easily converted to arachidonic acid, ALA conversion to EPA and DHA is 1% and 5% respectively [<xref rid="B65-nutrients-11-01179" ref-type="bibr">65</xref>].</p><p>Taking this into consideration as well as the omega-6 rich and omega-3 poor western diet [<xref rid="B66-nutrients-11-01179" ref-type="bibr">66</xref>], there is a risk of cardiovascular disease in western societies [<xref rid="B67-nutrients-11-01179" ref-type="bibr">67</xref>]. The omega-6 derived arachidonic acid (AA) serves as a precursor for the formation of oxylipins via cyclooxygenase (COX) [<xref rid="B68-nutrients-11-01179" ref-type="bibr">68</xref>]. Oxylipins have both beneficial and deleterious effects on the cardiovascular system. The best-characterized oxylipins are the ones derived from AA, and so far, the levels of AA-derived oxylipins in plasma have shown detrimental effects on cardiovascular health. Oxylipins derived from arachidonic acid promote inflammation [<xref rid="B69-nutrients-11-01179" ref-type="bibr">69</xref>,<xref rid="B70-nutrients-11-01179" ref-type="bibr">70</xref>], oxidative stress [<xref rid="B71-nutrients-11-01179" ref-type="bibr">71</xref>], and vasoconstriction [<xref rid="B71-nutrients-11-01179" ref-type="bibr">71</xref>,<xref rid="B72-nutrients-11-01179" ref-type="bibr">72</xref>]. The very first product of COX-induced oxidation of AA is prostaglandin G2 (PGG2) and subsequently, prostaglandin H2 (PGH2) which is further converted to other PGs and thromboxanes through PG and thromboxane synthase [<xref rid="B73-nutrients-11-01179" ref-type="bibr">73</xref>]. Prostaglandin E2 (PGE2) is involved in cardiac hypertrophy and ischemia [<xref rid="B74-nutrients-11-01179" ref-type="bibr">74</xref>,<xref rid="B75-nutrients-11-01179" ref-type="bibr">75</xref>]. Thromboxane A<sub>2</sub> has potent pro-aggregatory and vasoconstrictive properties [<xref rid="B76-nutrients-11-01179" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-11-01179" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-11-01179" ref-type="bibr">78</xref>]. Its concentration is reduced by aspirin administration [<xref rid="B76-nutrients-11-01179" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-11-01179" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-11-01179" ref-type="bibr">78</xref>]. 20-hydroxyeicosatetraenoic acid (20-HETE) induces vasoconstriction of porcine coronary arteries [<xref rid="B79-nutrients-11-01179" ref-type="bibr">79</xref>], whereas, 16-, 18-, 19- and 20-HETE metabolites promote vasodilation [<xref rid="B80-nutrients-11-01179" ref-type="bibr">80</xref>,<xref rid="B81-nutrients-11-01179" ref-type="bibr">81</xref>]. LOX-derived oxylipins affect the heart by promoting inflammation. Leukotrienes (LTs) lead to endothelial dysfunction, foam cell formation, and smooth muscle cell proliferation, all of which lead to atherosclerosis [<xref rid="B82-nutrients-11-01179" ref-type="bibr">82</xref>].</p><p>Not all oxylipins have a detrimental effect on the heart. CYP enzymes are highly expressed in the heart, and they are involved in converting AA to eicosanoids, which have a cardio-protective role [<xref rid="B83-nutrients-11-01179" ref-type="bibr">83</xref>,<xref rid="B84-nutrients-11-01179" ref-type="bibr">84</xref>,<xref rid="B85-nutrients-11-01179" ref-type="bibr">85</xref>]. Some of them, such as epoxy-eicosatrienoic acid (EpETrE), attenuate ischemia/reperfusion injury [<xref rid="B84-nutrients-11-01179" ref-type="bibr">84</xref>]. Moreover, EpETrE improved the electrical activity of the heart following ischemia/reperfusion injury [<xref rid="B86-nutrients-11-01179" ref-type="bibr">86</xref>,<xref rid="B87-nutrients-11-01179" ref-type="bibr">87</xref>]. This protective role is induced through multiple pathways involving mitochondrial and sarcolemmal potassium channels, p42/p44 MAPK (mitogen-activated protein kinase), and PI3K-AKT [<xref rid="B88-nutrients-11-01179" ref-type="bibr">88</xref>].</p><p>Dietary modulation of fatty acids can influence plasma oxylipin levels. Therefore, dietary fatty acid content has to be carefully considered since the oxylipins derived by specific dietary PUFAs can have a detrimental effect and lead to cardiovascular disease. For example, dietary LA leads to an increased production of 13-hydroxy-octadecadienoic acid (13-HODE) which has been shown to be increased in oxidized LDL, leading to its accumulation in macrophages, and ultimately to atherosclerosis [<xref rid="B89-nutrients-11-01179" ref-type="bibr">89</xref>].</p><p>In contrast, the metabolism of dietary omega-3 fatty acids can be protective in atherosclerosis, since it results in the production of oxylipins that can compete with the ones derived from omega-6 fatty acids and lead to a decreased cardiovascular risk [<xref rid="B90-nutrients-11-01179" ref-type="bibr">90</xref>,<xref rid="B91-nutrients-11-01179" ref-type="bibr">91</xref>,<xref rid="B92-nutrients-11-01179" ref-type="bibr">92</xref>]. Dietary supplementation with omega-3 fatty acids EPA and DHA show protective effects in the heart [<xref rid="B31-nutrients-11-01179" ref-type="bibr">31</xref>,<xref rid="B93-nutrients-11-01179" ref-type="bibr">93</xref>]. Epoxyeicosanoids derived by oxidation of EPA/DHA by CYP enzymes, such as 17,18-epoxy-EPA and 19,20-epoxy-DHA, shows potent antiarrhythmic effects [<xref rid="B94-nutrients-11-01179" ref-type="bibr">94</xref>]. The Singapore Chinese Health study included 744 acute myocardial infarction cases and 744 matched controls and showed not only an inverse association between acute myocardial infarctions and long-chain omega-3 PUFAs and stearic acid but also a positive correlation between AA and the risk of an acute myocardial infarction [<xref rid="B95-nutrients-11-01179" ref-type="bibr">95</xref>].</p><p>The fatty acid composition of chylomicrons can influence lipid deposition in macrophages that leads to atherosclerosis [<xref rid="B96-nutrients-11-01179" ref-type="bibr">96</xref>,<xref rid="B97-nutrients-11-01179" ref-type="bibr">97</xref>]. The chylomicrons that are rich in saturated fatty acids are more readily taken up by macrophages compared to the ones that contain omega-3 fatty acids [<xref rid="B98-nutrients-11-01179" ref-type="bibr">98</xref>]. Omega-3 fatty acids may also protect against atherosclerosis through a reduction in inflammatory signaling by decreasing the expression of various cytokines, as well as by a reduction in adhesion molecules [<xref rid="B99-nutrients-11-01179" ref-type="bibr">99</xref>]. EPA and DHA also promote the stabilization of atherosclerotic plaques, reducing the occurrence of acute fatal and nonfatal cardiovascular events [<xref rid="B100-nutrients-11-01179" ref-type="bibr">100</xref>]. Dietary flaxseed supplementation, through its rich content of ALA, inhibits the progression of atherosclerosis and promotes the regression of atherosclerotic plaque in animal models [<xref rid="B93-nutrients-11-01179" ref-type="bibr">93</xref>].</p></sec><sec id="sec5-nutrients-11-01179"><title>5. Fatty Acids and Ischemic Heart Disease</title><p>Fatty acid metabolism is altered in patients post myocardial infarction. In the healthy heart, 95% of the energy is produced by oxidative phosphorylation in mitochondria with the rest coming from glycolysis [<xref rid="B101-nutrients-11-01179" ref-type="bibr">101</xref>]. During myocardial ischemia/reperfusion injury, metabolism in the heart is significantly altered. During ischemia, the oxygen supply/demand ratio increases leading to a diminished mitochondrial oxygen phosphorylation in proportion to the decreased blood flow [<xref rid="B101-nutrients-11-01179" ref-type="bibr">101</xref>]. Under these conditions, glycolysis becomes the primary generator of ATP while glucose oxidation is inhibited [<xref rid="B101-nutrients-11-01179" ref-type="bibr">101</xref>]. The decoupling of these two processes results in the accumulation of lactate and H<sup>+</sup> [<xref rid="B102-nutrients-11-01179" ref-type="bibr">102</xref>]. Restoration of blood flow, however, leads to increased fatty acid &#x003b2; oxidation due to fatty acid accumulation, further diminishing glucose oxidation and leading to cellular acidosis [<xref rid="B103-nutrients-11-01179" ref-type="bibr">103</xref>]. This suggests that the inhibition of fatty acid oxidation can be beneficial during reperfusion. The only clinically available drug that can suppress fatty acid oxidation is trimetazidine. It inhibits 3-ketoacyl CoA thiolase [<xref rid="B104-nutrients-11-01179" ref-type="bibr">104</xref>], leading to decreased fatty acid oxidation, improved contractility, decreased injury and increased cardiac efficiency [<xref rid="B104-nutrients-11-01179" ref-type="bibr">104</xref>].</p><p>Phospholipids play an important role in ischemic reperfusion injury in the heart. Due to the presence of double bond PUFAs on the sn-2 position, phospholipids are highly susceptible to oxidation. This ultimately leads to the production of oxidized phospholipid species [<xref rid="B105-nutrients-11-01179" ref-type="bibr">105</xref>,<xref rid="B106-nutrients-11-01179" ref-type="bibr">106</xref>,<xref rid="B107-nutrients-11-01179" ref-type="bibr">107</xref>]. Using mass spectrometric analyses, a significant increase in oxidized phosphatidylcholine (oxPC) species was found following in vitro ischemia/reperfusion injury [<xref rid="B107-nutrients-11-01179" ref-type="bibr">107</xref>]. These oxidized phosphatidylcholine species have been predominantly fragmented species identified as 1-palmitoyl-2-(5&#x02032;-oxo-valeroyl)-<italic>sn</italic>-glycero-3-phosphocholine (POVPC), 1-palmitoyl-2-(9&#x02032;-oxo-nonanoyl)-<italic>sn</italic>-glycero-3-phosphocholine (PONPC), 1-palmitoyl-2-azelaoyl-<italic>sn</italic>-glycero-3-phosphocholine (PAzPC) and 1-palmitoyl-2-glutaryl-<italic>sn</italic>-glycero-3-phosphocholine (PGPC) [<xref rid="B107-nutrients-11-01179" ref-type="bibr">107</xref>]. The exogenous addition of these compounds to cardiomyocytes resulted in cell death, therefore, an increase in these oxPC species during reperfusion injury can be of great clinical importance [<xref rid="B107-nutrients-11-01179" ref-type="bibr">107</xref>].</p><p>Apart from a pharmacological approach for improving heart function and reducing the extent of ischemia/reperfusion injury, there is evidence that dietary intervention might be beneficial as well. A case-control study including 125 patients showed that ALA intake leads to a decreased risk of fatal ischemic heart disease [<xref rid="B75-nutrients-11-01179" ref-type="bibr">75</xref>]. The Lyon Diet Heart Study, a randomized secondary prevention trial demonstrated that the Mediterranean diet enriched in ALA leads to a 70% reduction in total deaths and 75% reduction in nonfatal myocardial infarctions [<xref rid="B108-nutrients-11-01179" ref-type="bibr">108</xref>]. In vitro treatment of adult rat cardiomyocytes with ALA led to multiple beneficial effects. It induced increased incorporation of ALA into membrane phospholipids, led to a reduction in cardiomyocyte cell death during ischemia/reperfusion injury [<xref rid="B105-nutrients-11-01179" ref-type="bibr">105</xref>]. Moreover, ALA treatment led to a decrease in production of oxidized phosphatidylcholines: 1-palmitoyl-2-(5&#x02032;-oxo-valeroyl)-<italic>sn</italic>-glycero-3-phosphocholine (POVPC) and 1-palmitoyl-2-glutaroyl-<italic>sn</italic>-glycero-3-phosphocholine (PGPC) [<xref rid="B105-nutrients-11-01179" ref-type="bibr">105</xref>].</p></sec><sec id="sec6-nutrients-11-01179"><title>6. Fatty Acid Metabolism in the Heart in Obesity</title><p>Although there is a clear association between fat intake and obesity [<xref rid="B109-nutrients-11-01179" ref-type="bibr">109</xref>], it is important to recognize that the type of fat ingested may influence obesity risk. This is particularly important with respect to <italic>n</italic>-3 fatty acids. For example, <italic>n</italic>-3 fatty acids may have a protective effect on cardiovascular diseases. However, epidemiological studies remain unclear whether <italic>n</italic>-3 PUFA intake decreases weight gain and abdominal fat. Although some studies have indicated a decrease in body fat with up to 6 g/day EPA and DHA consumption [<xref rid="B110-nutrients-11-01179" ref-type="bibr">110</xref>], other large prospective health studies such as the Nurses&#x02019; Health Study observed an increased prevalence of obesity with high fish intake and <italic>n</italic>-3 PUFA intake [<xref rid="B111-nutrients-11-01179" ref-type="bibr">111</xref>]. Taken together, these results cannot define a clear role of <italic>n</italic>-3 fatty acids in the prevalence of obesity, however, published data tens to indicate a decrease in obesity risk with <italic>n</italic>-3 fatty acid consumption. As well, most studies are limited by solely analyzing the effect of the <italic>n</italic>-3 fatty acids EPA and DHA on weight gain.</p><p>The effects of dietary <italic>n</italic>-6 PUFAs may be less controversial. Rat and mice work suggests that maternal intake of LA predisposes the fetus to AA, the metabolic bi-product of LA. Increased exposure of the fetus to AA has been associated with increased adipocyte production suggesting increased maternal LA intake may predispose an individual to increased adipocyte production [<xref rid="B112-nutrients-11-01179" ref-type="bibr">112</xref>,<xref rid="B113-nutrients-11-01179" ref-type="bibr">113</xref>]. Furthermore, studies conducted by Massiera and colleagues [<xref rid="B66-nutrients-11-01179" ref-type="bibr">66</xref>] suggest that when rat diets were supplemented with 55% LA as a % of the total lipid fraction (19% total energy) for four generations, there was a progressive weight gain in each of four generations [<xref rid="B66-nutrients-11-01179" ref-type="bibr">66</xref>]. This evidence suggests that the early development of obesity may be correlated to increased <italic>n</italic>-6 fatty acid consumption. Taken together, these studies suggest that <italic>n</italic>-3 and <italic>n</italic>-6 PUFAs have differential effects on obesity. However, more study is necessary to fully understand this phenomenon.</p><p>A diseased condition can either cause changes in fatty acid uptake or its oxidation, or, conversely, the disease can be caused by a dysfunction of the fatty acid uptake/oxidation processes. Understanding the role of proteins and pathways involved in fatty acid uptake and the role that changes in metabolism may play is particularly important in diseases of the heart. Since substrate utilization changes during stressful situations, analyzing fatty acid uptake and oxidation patterns are critical to a better understanding of the progression of cardiac diseases.</p><p>For example, insulin resistance in the heart and skeletal muscle is associated with a reduced response to increased circulating free fatty acids [<xref rid="B114-nutrients-11-01179" ref-type="bibr">114</xref>]. This is a common occurrence in insulin-resistant conditions such as obesity and type 2 diabetes [<xref rid="B114-nutrients-11-01179" ref-type="bibr">114</xref>]. When the uptake of fatty acids exceeds the rate of beta-oxidation, intramuscular lipids can accumulate leading to lipotoxicity [<xref rid="B15-nutrients-11-01179" ref-type="bibr">15</xref>]. CD36, therefore, plays an important role in increasing long-chain fatty acid (LCFA) uptake into the heart and increasing lipid accumulation when beta oxidation rates do not meet the energy needs of the heart [<xref rid="B15-nutrients-11-01179" ref-type="bibr">15</xref>]. Treatment with an inhibitor of CD36, sulfo-<italic>N</italic>-succimidyl-palmitate (SSO), decreased LCFA uptake and the subsequent accumulation of lipids in the heart. CD36 also plays a role in atherosclerosis since CD36 is a class B scavenger protein and associated with macrophage infiltration. CD36 inhibition also leads to complications in the heart, such as development of hypertrophy [<xref rid="B115-nutrients-11-01179" ref-type="bibr">115</xref>]. Taken together, these studies suggest a clear role of CD36 in the progression of CVD. However, while CD36 knock-out may play a beneficial role in limiting disease progression (such as type 2 diabetes), it is still important for basal metabolic function. Long term use of agents such as SSO that inhibit FA uptake through the blocking of CD36 increase the risk of cardiac hypertrophy in rats [<xref rid="B116-nutrients-11-01179" ref-type="bibr">116</xref>]. Conversely, type 2 diabetes is associated with increased intramyocardial levels of TG [<xref rid="B117-nutrients-11-01179" ref-type="bibr">117</xref>] which, despite the early association with ventricular dysfunction, can have beneficial effects. Increased intramyocardial TG as well as elevated levels of serum PUFAs were protective in the failing heart [<xref rid="B118-nutrients-11-01179" ref-type="bibr">118</xref>] and can be important for maintaining ventricular function in both healthy individuals [<xref rid="B119-nutrients-11-01179" ref-type="bibr">119</xref>] as well as individuals with type 2 diabetes [<xref rid="B120-nutrients-11-01179" ref-type="bibr">120</xref>].</p></sec><sec sec-type="conclusions" id="sec7-nutrients-11-01179"><title>7. Conclusions</title><p>Fatty acids represent a class of molecules with a large structural and functional diversity. They have a detrimental role in the heart functioning as a primary energy source in controlled conditions. The main point of this review was to highlight the metabolism of fatty acids in the heart in health and disease as well as to draw the attention to the importance of dietary fats. Dietary fatty acid intake can have both detrimental as well as beneficial effects on heart fatty acid metabolism. However, due to their bitter taste, fatty acid ingestion could be reduced. Here, we summarized the studies describing different methods that could be used to reduce the bitterness of fatty acids in order to improve their ingestion and the beneficial effects these ingested fatty acids, particularly PUFAs may have on our cardiovascular health.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by CIHR, Western Grain Research Foundation, Saskflax, ARDI and St Boniface Hospital Foundation.</p></ack><notes><title>Author Contributions</title><p>For conceptualization, A.S., R.G. and G.N.P.; resources, A.R. and G.N.P.; writing&#x02014;original draft preparation, A.S. and R.G.; writing&#x02014;review and editing, A.S., R.G., M.A., A.R., and G.N.P.; supervision, G.N.P.; funding acquisition, G.N.P. and A.R.</p></notes><notes><title>Funding</title><p>This work was supported by grants to AR from Heart and Stroke Foundation of Canada and a Foundation grant to GNP from CIHR, as well as to GNP from the Western Grain Research Foundation, Saskflax, ARDI and St Boniface Hospital Foundation.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</p></notes><app-group><app id="app1-nutrients-11-01179"><title>Appendix A</title><fig id="nutrients-11-01179-f0A1" orientation="portrait" position="anchor"><label>Figure A1</label><caption><p>Metabolism of ALA into EPA and DHA by specific enzymes. ALA: alpha linolenic acid; EPA: eicosapentaenoic acid; DHA: docosahexanoeic acid.</p></caption><graphic xlink:href="nutrients-11-01179-g0A1"/></fig></app></app-group><ref-list><title>References</title><ref id="B1-nutrients-11-01179"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busch</surname><given-names>J.L.</given-names></name><name><surname>Hrncirik</surname><given-names>K.</given-names></name><name><surname>Bulukin</surname><given-names>E.</given-names></name><name><surname>Boucon</surname><given-names>C.</given-names></name><name><surname>Mascini</surname><given-names>M.</given-names></name></person-group><article-title>Biosensor measurements of polar phenolics for the assessment of the bitterness and pungency of virgin olive oil</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>4371</fpage><lpage>4377</lpage><pub-id pub-id-type="doi">10.1021/jf060103m</pub-id><?supplied-pmid 16756369?><pub-id pub-id-type="pmid">16756369</pub-id></element-citation></ref><ref id="B2-nutrients-11-01179"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lao</surname><given-names>Y.W.</given-names></name><name><surname>Mackenzie</surname><given-names>K.</given-names></name><name><surname>Vincent</surname><given-names>W.</given-names></name><name><surname>Krokhin</surname><given-names>O.V.</given-names></name></person-group><article-title>Characterization and complete separation of major cyclolinopeptides in flaxseed oil by reversed-phase chromatography</article-title><source>J. Sep. Sci.</source><year>2014</year><volume>37</volume><fpage>1788</fpage><lpage>1796</lpage><pub-id pub-id-type="doi">10.1002/jssc.201400193</pub-id><pub-id pub-id-type="pmid">24788784</pub-id></element-citation></ref><ref id="B3-nutrients-11-01179"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitaglione</surname><given-names>P.</given-names></name><name><surname>Savarese</surname><given-names>M.</given-names></name><name><surname>Paduano</surname><given-names>A.</given-names></name><name><surname>Scalfi</surname><given-names>L.</given-names></name><name><surname>Fogliano</surname><given-names>V.</given-names></name><name><surname>Sacchi</surname><given-names>R.</given-names></name></person-group><article-title>Healthy virgin olive oil: A matter of bitterness</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2015</year><volume>55</volume><fpage>1808</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.1080/10408398.2012.708685</pub-id><?supplied-pmid 24915318?><pub-id pub-id-type="pmid">24915318</pub-id></element-citation></ref><ref id="B4-nutrients-11-01179"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caponio</surname><given-names>F.</given-names></name><name><surname>Durante</surname><given-names>V.</given-names></name><name><surname>Varva</surname><given-names>G.</given-names></name><name><surname>Silletti</surname><given-names>R.</given-names></name><name><surname>Previtali</surname><given-names>M.A.</given-names></name><name><surname>Viggiani</surname><given-names>I.</given-names></name><name><surname>Squeo</surname><given-names>G.</given-names></name><name><surname>Summo</surname><given-names>C.</given-names></name><name><surname>Pasqualone</surname><given-names>A.</given-names></name><name><surname>Gomes</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Effect of infusion of spices into the oil vs. combined malaxation of olive paste and spices on quality of naturally flavoured virgin olive oils</article-title><source>Food Chem.</source><year>2016</year><volume>202</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.02.005</pub-id><?supplied-pmid 26920288?><pub-id pub-id-type="pmid">26920288</pub-id></element-citation></ref><ref id="B5-nutrients-11-01179"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000fc;hl</surname><given-names>L.</given-names></name><name><surname>Matth&#x000e4;us</surname><given-names>B.</given-names></name><name><surname>Fehling</surname><given-names>E.</given-names></name><name><surname>Wiege</surname><given-names>B.</given-names></name><name><surname>Lehmann</surname><given-names>B.</given-names></name><name><surname>Luftmann</surname><given-names>H.</given-names></name><name><surname>Bergander</surname><given-names>K.</given-names></name><name><surname>Quiroga</surname><given-names>K.</given-names></name><name><surname>Scheipers</surname><given-names>A.</given-names></name><name><surname>Frank</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Identification of bitter off-taste compounds in the stored cold pressed linseed oil</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>7864</fpage><lpage>7868</lpage><pub-id pub-id-type="doi">10.1021/jf071136k</pub-id><pub-id pub-id-type="pmid">17715895</pub-id></element-citation></ref><ref id="B6-nutrients-11-01179"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;zquez-Ara&#x000fa;jo</surname><given-names>L.</given-names></name><name><surname>Adhikari</surname><given-names>K.</given-names></name><name><surname>Chambers</surname><given-names>E.</given-names><suffix>4th</suffix></name><name><surname>Chambers</surname><given-names>D.H.</given-names></name><name><surname>Carbonell-Barrachina</surname><given-names>A.A.</given-names></name></person-group><article-title>Cross-cultural perception of six commercial olive oils: A study with Spanish and US consumers</article-title><source>Food Sci. Technol. Int.</source><year>2015</year><volume>21</volume><fpage>454</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1177/1082013214543806</pub-id><pub-id pub-id-type="pmid">25028154</pub-id></element-citation></ref><ref id="B7-nutrients-11-01179"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aliani</surname><given-names>M.</given-names></name><name><surname>Tyland</surname><given-names>D.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Effect of flax addition on the flavor profile of muffins and snack bars</article-title><source>Food Res. Int.</source><year>2011</year><volume>44</volume><fpage>2489</fpage><lpage>2496</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2011.01.044</pub-id></element-citation></ref><ref id="B8-nutrients-11-01179"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousfi</surname><given-names>K.</given-names></name><name><surname>Cayuela</surname><given-names>J.A.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>J.M.</given-names></name></person-group><article-title>Reduction of virgin olive oil bitterness by fruit cold storage</article-title><source>J. Agric. Food Chem.</source><year>2008</year><volume>56</volume><fpage>10085</fpage><lpage>10091</lpage><pub-id pub-id-type="doi">10.1021/jf801951g</pub-id><pub-id pub-id-type="pmid">18937491</pub-id></element-citation></ref><ref id="B9-nutrients-11-01179"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>J.M.</given-names></name><name><surname>Yousfi</surname><given-names>K.</given-names></name><name><surname>Mateos</surname><given-names>R.</given-names></name><name><surname>Olmo</surname><given-names>M.</given-names></name><name><surname>Cert</surname><given-names>A.</given-names></name></person-group><article-title>Reduction of oil bitterness by heating of olive (Olea europaea) fruits</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>4231</fpage><lpage>4235</lpage><pub-id pub-id-type="doi">10.1021/jf001302n</pub-id><pub-id pub-id-type="pmid">11559116</pub-id></element-citation></ref><ref id="B10-nutrients-11-01179"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koprivnjak</surname><given-names>O.</given-names></name><name><surname>&#x00160;kevin</surname><given-names>D.</given-names></name><name><surname>Petri&#x0010d;evi&#x00107;</surname><given-names>S.</given-names></name><name><surname>Brki&#x00107; Bubola</surname><given-names>K.</given-names></name><name><surname>Mokrov&#x0010d;ak</surname><given-names>&#x0017d;.</given-names></name></person-group><article-title>Bitterness, odor properties and volatile compounds of virgin olive oil with phospholipids addition</article-title><source>LWT-Food Sci. Technol.</source><year>2009</year><volume>42</volume><fpage>50</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2008.05.002</pub-id></element-citation></ref><ref id="B11-nutrients-11-01179"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abenoza</surname><given-names>M.</given-names></name><name><surname>Raso</surname><given-names>J.</given-names></name><name><surname>Oria</surname><given-names>R.</given-names></name><name><surname>S&#x000e1;nchez-Gimeno</surname><given-names>A.C.</given-names></name></person-group><article-title>Modulating the bitterness of Empeltre olive oil by partitioning polyphenols between oil and water phases: Effect on quality and shelf life</article-title><source>Food Sci. Technol. Int.</source><year>2019</year><volume>25</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1177/1082013218795803</pub-id><?supplied-pmid 30170510?><pub-id pub-id-type="pmid">30170510</pub-id></element-citation></ref><ref id="B12-nutrients-11-01179"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austria</surname><given-names>J.A.</given-names></name><name><surname>Aliani</surname><given-names>M.</given-names></name><name><surname>Malcolmson</surname><given-names>L.J.</given-names></name><name><surname>Dibrov</surname><given-names>E.</given-names></name><name><surname>Blackwood</surname><given-names>E.P.</given-names></name><name><surname>Maddaford</surname><given-names>T.G.</given-names></name><name><surname>Guzman</surname><given-names>R.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Daily food choices over one year when patient diets are supplemented with milled flaxseed</article-title><source>J. Funct. Foods</source><year>2016</year><volume>26</volume><fpage>772</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2016.08.045</pub-id></element-citation></ref><ref id="B13-nutrients-11-01179"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austria</surname><given-names>J.A.</given-names></name><name><surname>Richard</surname><given-names>M.N.</given-names></name><name><surname>Chahine</surname><given-names>M.N.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Malcolmson</surname><given-names>L.J.</given-names></name><name><surname>Dupasquier</surname><given-names>C.M.C.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Bioavailability of alpha linolenic acid in subjects after ingestion of three different forms of flaxseed</article-title><source>J. Am. Coll. Nutr.</source><year>2008</year><volume>27</volume><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1080/07315724.2008.10719693</pub-id><pub-id pub-id-type="pmid">18689552</pub-id></element-citation></ref><ref id="B14-nutrients-11-01179"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaul</surname><given-names>N.</given-names></name><name><surname>Kreml</surname><given-names>R.</given-names></name><name><surname>Austria</surname><given-names>J.A.</given-names></name><name><surname>Landry</surname><given-names>M.N.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Dibrov</surname><given-names>E.</given-names></name><name><surname>Hirono</surname><given-names>S.</given-names></name><name><surname>Zettler</surname><given-names>M.E.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>A comparative effect of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers</article-title><source>J. Am. Coll. Nutr.</source><year>2008</year><volume>27</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1080/07315724.2008.10719674</pub-id><?supplied-pmid 18460481?><pub-id pub-id-type="pmid">18460481</pub-id></element-citation></ref><ref id="B15-nutrients-11-01179"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name><name><surname>Ussher</surname><given-names>J.R.</given-names></name><name><surname>Folmes</surname><given-names>C.D.</given-names></name><name><surname>Jaswal</surname><given-names>J.S.</given-names></name><name><surname>Stanley</surname><given-names>W.C.</given-names></name></person-group><article-title>Myocardial fatty acid metabolism in health and disease</article-title><source>Physiol. Rev.</source><year>2010</year><volume>90</volume><fpage>207</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1152/physrev.00015.2009</pub-id><pub-id pub-id-type="pmid">20086077</pub-id></element-citation></ref><ref id="B16-nutrients-11-01179"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>D.</given-names></name><name><surname>Pulinilkunnil</surname><given-names>T.</given-names></name><name><surname>Qi</surname><given-names>D.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Abrahani</surname><given-names>A.</given-names></name><name><surname>Rodrigues</surname><given-names>B.</given-names></name></person-group><article-title>The metabolic &#x0201c;switch&#x0201d; AMPK regulates cardiac heparin-releasable lipoprotein lipase</article-title><source>Am. J. Physiol. Endocrinol. Metab.</source><year>2005</year><volume>288</volume><fpage>E246</fpage><lpage>E253</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00211.2004</pub-id><pub-id pub-id-type="pmid">15328075</pub-id></element-citation></ref><ref id="B17-nutrients-11-01179"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.Y.</given-names></name><name><surname>Ly</surname><given-names>L.H.</given-names></name><name><surname>Barhoumi</surname><given-names>R.</given-names></name><name><surname>McMurray</surname><given-names>D.N.</given-names></name><name><surname>Chapkin</surname><given-names>R.S.</given-names></name></person-group><article-title>Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production</article-title><source>J. Immunol.</source><year>2004</year><volume>173</volume><fpage>6151</fpage><lpage>6160</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.10.6151</pub-id><pub-id pub-id-type="pmid">15528352</pub-id></element-citation></ref><ref id="B18-nutrients-11-01179"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S.W.</given-names></name><name><surname>Kwon</surname><given-names>M.J.</given-names></name><name><surname>Choi</surname><given-names>A.M.</given-names></name><name><surname>Kim</surname><given-names>H.P.</given-names></name><name><surname>Nakahira</surname><given-names>K.</given-names></name><name><surname>Hwang</surname><given-names>D.H.</given-names></name></person-group><article-title>Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>27384</fpage><lpage>27392</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.044065</pub-id><pub-id pub-id-type="pmid">19648648</pub-id></element-citation></ref><ref id="B19-nutrients-11-01179"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tribulova</surname><given-names>N.</given-names></name><name><surname>Szeiffova Bacova</surname><given-names>B.</given-names></name><name><surname>Egan Benova</surname><given-names>T.</given-names></name><name><surname>Knezl</surname><given-names>V.</given-names></name><name><surname>Barancik</surname><given-names>M.</given-names></name><name><surname>Slezak</surname><given-names>J.</given-names></name></person-group><article-title>Omega-3 index and anti-arrhythmic potential of omega-3 PUFAs</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>1191</elocation-id><pub-id pub-id-type="doi">10.3390/nu9111191</pub-id></element-citation></ref><ref id="B20-nutrients-11-01179"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caligiuri</surname><given-names>S.P.B.</given-names></name><name><surname>Parikh</surname><given-names>M.</given-names></name><name><surname>Stamenkovic</surname><given-names>A.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name><name><surname>Aukema</surname><given-names>H.M.</given-names></name></person-group><article-title>Dietary modulation of oxylipins in cardiovascular disease and aging</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2017</year><volume>313</volume><fpage>H903</fpage><lpage>H918</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00201.2017</pub-id><pub-id pub-id-type="pmid">28801523</pub-id></element-citation></ref><ref id="B21-nutrients-11-01179"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capoulade</surname><given-names>R.</given-names></name><name><surname>Chan</surname><given-names>K.L.</given-names></name><name><surname>Yeang</surname><given-names>C.</given-names></name><name><surname>Mathieu</surname><given-names>P.</given-names></name><name><surname>Bosse</surname><given-names>Y.</given-names></name><name><surname>Dumesnil</surname><given-names>J.G.</given-names></name><name><surname>Tam</surname><given-names>J.W.</given-names></name><name><surname>Teo</surname><given-names>K.K.</given-names></name><name><surname>Mahmut</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis</article-title><source>J. Am. Coll. Cardiol.</source><year>2015</year><volume>66</volume><fpage>1236</fpage><lpage>1246</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2015.07.020</pub-id><pub-id pub-id-type="pmid">26361154</pub-id></element-citation></ref><ref id="B22-nutrients-11-01179"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsimikas</surname><given-names>S.</given-names></name><name><surname>Brilakis</surname><given-names>E.S.</given-names></name><name><surname>Miller</surname><given-names>E.R.</given-names></name><name><surname>McConnell</surname><given-names>J.P.</given-names></name><name><surname>Lennon</surname><given-names>R.J.</given-names></name><name><surname>Kornman</surname><given-names>K.S.</given-names></name><name><surname>Witztum</surname><given-names>J.L.</given-names></name><name><surname>Berger</surname><given-names>P.B.</given-names></name></person-group><article-title>Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease</article-title><source>N. Engl. J. Med.</source><year>2005</year><volume>353</volume><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa043175</pub-id><pub-id pub-id-type="pmid">16000355</pub-id></element-citation></ref><ref id="B23-nutrients-11-01179"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K.K.</given-names></name><name><surname>Frasier-Scott</surname><given-names>K.</given-names></name><name><surname>Hatzakis</surname><given-names>H.</given-names></name></person-group><article-title>Endothelial cell function in hemostasis and thrombosis</article-title><source>Adv. Exp. Med. Biol.</source><year>1988</year><volume>242</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">3149868</pub-id></element-citation></ref><ref id="B24-nutrients-11-01179"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamenkovic</surname><given-names>A.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name><name><surname>Ravandi</surname><given-names>A.</given-names></name></person-group><article-title>Oxidized phosphatidylcholine: Not just another brick in the wall</article-title><source>Can. J. Physiol. Pharmacol.</source><year>2018</year><volume>16</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1139/cjpp-2018-0490</pub-id><?supplied-pmid 30444647?><pub-id pub-id-type="pmid">30444647</pub-id></element-citation></ref><ref id="B25-nutrients-11-01179"><label>25.</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Stamenkovic</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Hara</surname><given-names>K.A.</given-names></name><name><surname>Nelson</surname><given-names>D.C.</given-names></name><name><surname>Maddaford</surname><given-names>T.G.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Maddaford</surname><given-names>G.G.</given-names></name><name><surname>Dibrov</surname><given-names>E.</given-names></name><name><surname>Aghanoori</surname><given-names>M.R.</given-names></name><name><surname>Fernyhough</surname><given-names>P.</given-names></name><name><surname>Kirshenbaum</surname><given-names>L.A.</given-names></name><etal/></person-group><article-title>Oxidized phosphatidylcholines cause ferroptosis in cardiomyocytes during ischemia/reperfusion injury</article-title><year>2019</year><comment>in press</comment></element-citation></ref><ref id="B26-nutrients-11-01179"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamenkovic</surname><given-names>A.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name><name><surname>Ravandi</surname><given-names>A.</given-names></name></person-group><article-title>Phospholipid oxidation products in ferroptotic myocardial cell death</article-title><source>Am. J. Physiol.</source><year>2019</year><comment>in press</comment><pub-id pub-id-type="doi">10.1152/ajpheart.00076.2019</pub-id></element-citation></ref><ref id="B27-nutrients-11-01179"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>D.H.</given-names></name><name><surname>Cogan</surname><given-names>J.D.</given-names></name><name><surname>Phillips</surname><given-names>J.A.</given-names><suffix>3rd</suffix></name><name><surname>Schnetz-Boutaud</surname><given-names>N.</given-names></name><name><surname>Milne</surname><given-names>G.L.</given-names></name><name><surname>Iverson</surname><given-names>T.</given-names></name><name><surname>Stein</surname><given-names>J.A.</given-names></name><name><surname>Brenner</surname><given-names>D.A.</given-names></name><name><surname>Morrow</surname><given-names>J.D.</given-names></name><name><surname>Boutaud</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction</article-title><source>J. Clin. Investig.</source><year>2008</year><volume>118</volume><fpage>2121</fpage><lpage>2131</lpage><?supplied-pmid 18451993?><pub-id pub-id-type="pmid">18451993</pub-id></element-citation></ref><ref id="B28-nutrients-11-01179"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>H.D.</given-names></name><name><surname>Meisel</surname><given-names>J.A.</given-names></name><name><surname>de Meijer</surname><given-names>V.E.</given-names></name><name><surname>Gura</surname><given-names>K.M.</given-names></name><name><surname>Puder</surname><given-names>M.</given-names></name></person-group><article-title>The essentiality of arachidonic acid and docosahexaenoic acid</article-title><source>Prostaglandins Leukot. Essent. Fatty Acids</source><year>2009</year><volume>81</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.plefa.2009.05.020</pub-id><pub-id pub-id-type="pmid">19540099</pub-id></element-citation></ref><ref id="B29-nutrients-11-01179"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michas</surname><given-names>G.</given-names></name><name><surname>Micha</surname><given-names>R.</given-names></name><name><surname>Zampelas</surname><given-names>A.</given-names></name></person-group><article-title>Dietary fats and cardiovascular disease: Putting together the pieces of a complicated puzzle</article-title><source>Atherosclerosis</source><year>2014</year><volume>234</volume><fpage>320</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.03.013</pub-id><?supplied-pmid 24727233?><pub-id pub-id-type="pmid">24727233</pub-id></element-citation></ref><ref id="B30-nutrients-11-01179"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simopoulos</surname><given-names>A.P.</given-names></name></person-group><article-title>The importance of the ratio of omega-6/omega3 essential fatty acids</article-title><source>Biomed. Pharmacother.</source><year>2002</year><volume>56</volume><fpage>365</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/S0753-3322(02)00253-6</pub-id><pub-id pub-id-type="pmid">12442909</pub-id></element-citation></ref><ref id="B31-nutrients-11-01179"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willett</surname><given-names>W.C.</given-names></name></person-group><article-title>The role of dietary n-6 fatty acids in the prevention of cardiovascular disease</article-title><source>J. Cardiovasc. Med.</source><year>2007</year><volume>8</volume><issue>Suppl. 1</issue><fpage>S42</fpage><lpage>S45</lpage><pub-id pub-id-type="doi">10.2459/01.JCM.0000289275.72556.13</pub-id></element-citation></ref><ref id="B32-nutrients-11-01179"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gershwin</surname><given-names>M.E.</given-names></name><name><surname>Greenwood</surname><given-names>M.R.C.</given-names></name><collab>New York Academy of Sciences</collab></person-group><source>Foods for Health in the 21st Century: A Roadmap for the Future</source><publisher-name>Wiley-Blackwell</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2010</year></element-citation></ref><ref id="B33-nutrients-11-01179"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>C.M.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Patenaude</surname><given-names>A.F.</given-names></name><name><surname>McCullough</surname><given-names>R.S.</given-names></name><name><surname>Blackwood</surname><given-names>D.P.</given-names></name><name><surname>Chouinard</surname><given-names>P.Y.</given-names></name><name><surname>Paquin</surname><given-names>P.</given-names></name><name><surname>Lamarche</surname><given-names>B.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice</article-title><source>J. Nutr.</source><year>2010</year><volume>140</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.3945/jn.109.105163</pub-id><pub-id pub-id-type="pmid">19923390</pub-id></element-citation></ref><ref id="B34-nutrients-11-01179"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>C.M.</given-names></name><name><surname>McCullough</surname><given-names>R.S.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Maddaford</surname><given-names>T.G.</given-names></name><name><surname>Dibrov</surname><given-names>E.</given-names></name><name><surname>Blackwood</surname><given-names>D.P.</given-names></name><name><surname>Austria</surname><given-names>J.A.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Trans-fatty acids in the diet stimulate atherosclerosis</article-title><source>Metabolism</source><year>2009</year><volume>58</volume><fpage>1802</fpage><lpage>1808</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2009.06.010</pub-id><?supplied-pmid 19631352?><pub-id pub-id-type="pmid">19631352</pub-id></element-citation></ref><ref id="B35-nutrients-11-01179"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>C.M.</given-names></name><name><surname>McCullough</surname><given-names>R.S.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Patenaude</surname><given-names>A.</given-names></name><name><surname>LaVallee</surname><given-names>R.K.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>The alpha-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2011</year><volume>301</volume><fpage>H2220</fpage><lpage>H2226</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00958.2010</pub-id><?supplied-pmid 21963840?><pub-id pub-id-type="pmid">21963840</pub-id></element-citation></ref><ref id="B36-nutrients-11-01179"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>C.M.</given-names></name><name><surname>Rodriguez-Leyva</surname><given-names>D.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed</article-title><source>Appl. Physiol. Nutr. Metab.</source><year>2009</year><volume>34</volume><fpage>965</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1139/H09-087</pub-id><?supplied-pmid 19935863?><pub-id pub-id-type="pmid">19935863</pub-id></element-citation></ref><ref id="B37-nutrients-11-01179"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>R.</given-names></name><name><surname>Lytwyn</surname><given-names>M.S.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Differential effects of trans and polyunsaturated fatty acids on ischemia/reperfusion injury and its associated cardiovascular disease states</article-title><source>Curr. Pharm. Des.</source><year>2013</year><volume>19</volume><fpage>6858</fpage><lpage>6863</lpage><pub-id pub-id-type="doi">10.2174/138161281939131127111018</pub-id><pub-id pub-id-type="pmid">23590155</pub-id></element-citation></ref><ref id="B38-nutrients-11-01179"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadj Ahmed</surname><given-names>S.</given-names></name><name><surname>Kharroubi</surname><given-names>W.</given-names></name><name><surname>Kaoubaa</surname><given-names>N.</given-names></name><name><surname>Zarrouk</surname><given-names>A.</given-names></name><name><surname>Batbout</surname><given-names>F.</given-names></name><name><surname>Gamra</surname><given-names>H.</given-names></name><name><surname>Najjar</surname><given-names>M.F.</given-names></name><name><surname>Lizard</surname><given-names>G.</given-names></name><name><surname>Hininger-Favier</surname><given-names>I.</given-names></name><name><surname>Hammami</surname><given-names>M.</given-names></name></person-group><article-title>Correlation of trans fatty acids with the severity of coronary artery disease lesions</article-title><source>Lipids Health Dis.</source><year>2018</year><volume>17</volume><fpage>52</fpage><pub-id pub-id-type="doi">10.1186/s12944-018-0699-3</pub-id><pub-id pub-id-type="pmid">29544473</pub-id></element-citation></ref><ref id="B39-nutrients-11-01179"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadj Ahmed</surname><given-names>S.</given-names></name><name><surname>Kaoubaa</surname><given-names>N.</given-names></name><name><surname>Kharroubi</surname><given-names>W.</given-names></name><name><surname>Zarrouk</surname><given-names>A.</given-names></name><name><surname>Najjar</surname><given-names>M.F.</given-names></name><name><surname>Batbout</surname><given-names>F.</given-names></name><name><surname>Gamra</surname><given-names>H.</given-names></name><name><surname>Lizard</surname><given-names>G.</given-names></name><name><surname>Hammami</surname><given-names>M.</given-names></name></person-group><article-title>Association of plasma fatty acid alteration with the severity of coronary artery disease lesions in Tunisian patients</article-title><source>Lipids Health Dis.</source><year>2017</year><volume>16</volume><fpage>154</fpage><pub-id pub-id-type="doi">10.1186/s12944-017-0538-y</pub-id><pub-id pub-id-type="pmid">28806974</pub-id></element-citation></ref><ref id="B40-nutrients-11-01179"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bourne</surname><given-names>G.H.</given-names></name></person-group><source>Aspects of Human Nutrition</source><publisher-name>Karger</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1988</year></element-citation></ref><ref id="B41-nutrients-11-01179"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siri-Tarino</surname><given-names>P.W.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>F.B.</given-names></name><name><surname>Krauss</surname><given-names>R.M.</given-names></name></person-group><article-title>Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease</article-title><source>Am. J. Clin. Nutr.</source><year>2010</year><volume>91</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2009.27725</pub-id><?supplied-pmid 20071648?><pub-id pub-id-type="pmid">20071648</pub-id></element-citation></ref><ref id="B42-nutrients-11-01179"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsen</surname><given-names>M.U.</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>E.J.</given-names></name><name><surname>Heitmann</surname><given-names>B.L.</given-names></name><name><surname>Pereira</surname><given-names>M.A.</given-names></name><name><surname>Balter</surname><given-names>K.</given-names></name><name><surname>Fraser</surname><given-names>G.E.</given-names></name><name><surname>Goldbourt</surname><given-names>U.</given-names></name><name><surname>Hallmans</surname><given-names>G.</given-names></name><name><surname>Knekt</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Major types of dietary fat and risk of coronary heart disease: A pooled analysis of 11 cohort studies</article-title><source>Am. J. Clin. Nutr.</source><year>2009</year><volume>89</volume><fpage>1425</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2008.27124</pub-id><?supplied-pmid 19211817?><pub-id pub-id-type="pmid">19211817</pub-id></element-citation></ref><ref id="B43-nutrients-11-01179"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Hruby</surname><given-names>A.</given-names></name><name><surname>Bernstein</surname><given-names>A.M.</given-names></name><name><surname>Ley</surname><given-names>S.H.</given-names></name><name><surname>Wang</surname><given-names>D.D.</given-names></name><name><surname>Chiuve</surname><given-names>S.E.</given-names></name><name><surname>Sampson</surname><given-names>L.</given-names></name><name><surname>Rexrode</surname><given-names>K.M.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><etal/></person-group><article-title>Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: A prospective cohort study</article-title><source>J. Am. Coll. Cardiol.</source><year>2015</year><volume>66</volume><fpage>1538</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2015.07.055</pub-id><?supplied-pmid 26429077?><pub-id pub-id-type="pmid">26429077</pub-id></element-citation></ref><ref id="B44-nutrients-11-01179"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>A.C.</given-names></name><name><surname>Jennings</surname><given-names>R.B.</given-names></name></person-group><article-title>Myocardial calcium and magnesium in acute ischemic injury</article-title><source>Am. J. Pathol.</source><year>1972</year><volume>67</volume><fpage>417</fpage><lpage>440</lpage><?supplied-pmid 5033257?><pub-id pub-id-type="pmid">5033257</pub-id></element-citation></ref><ref id="B45-nutrients-11-01179"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ander</surname><given-names>B.P.</given-names></name><name><surname>Hurtado</surname><given-names>C.</given-names></name><name><surname>Raposo</surname><given-names>C.S.</given-names></name><name><surname>Maddaford</surname><given-names>T.G.</given-names></name><name><surname>Deniset</surname><given-names>J.F.</given-names></name><name><surname>Hryshko</surname><given-names>L.V.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name><name><surname>Lukas</surname><given-names>A.</given-names></name></person-group><article-title>Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid</article-title><source>Cardiovasc. Res.</source><year>2007</year><volume>73</volume><fpage>395</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.09.013</pub-id><?supplied-pmid 17059813?><pub-id pub-id-type="pmid">17059813</pub-id></element-citation></ref><ref id="B46-nutrients-11-01179"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djousse</surname><given-names>L.</given-names></name><name><surname>Pankow</surname><given-names>J.S.</given-names></name><name><surname>Eckfeldt</surname><given-names>J.H.</given-names></name><name><surname>Folsom</surname><given-names>A.R.</given-names></name><name><surname>Hopkins</surname><given-names>P.N.</given-names></name><name><surname>Province</surname><given-names>M.A.</given-names></name><name><surname>Hong</surname><given-names>Y.</given-names></name><name><surname>Ellison</surname><given-names>R.C.</given-names></name></person-group><article-title>Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study</article-title><source>Am. J. Clin. Nutr.</source><year>2001</year><volume>74</volume><fpage>612</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1093/ajcn/74.5.612</pub-id><?supplied-pmid 11684529?><pub-id pub-id-type="pmid">11684529</pub-id></element-citation></ref><ref id="B47-nutrients-11-01179"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhaka</surname><given-names>V.</given-names></name><name><surname>Gulia</surname><given-names>N.</given-names></name><name><surname>Ahlawat</surname><given-names>K.S.</given-names></name><name><surname>Khatkar</surname><given-names>B.S.</given-names></name></person-group><article-title>Trans fats-sources, health risks and alternative approach&#x02014;A review</article-title><source>J. Food Sci. Technol.</source><year>2011</year><volume>48</volume><fpage>534</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1007/s13197-010-0225-8</pub-id><pub-id pub-id-type="pmid">23572785</pub-id></element-citation></ref><ref id="B48-nutrients-11-01179"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mensink</surname><given-names>R.P.</given-names></name></person-group><article-title>Metabolic and health effects of isomeric fatty acids</article-title><source>Curr. Opin. Lipidol.</source><year>2005</year><volume>16</volume><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1097/00041433-200502000-00006</pub-id><pub-id pub-id-type="pmid">15650560</pub-id></element-citation></ref><ref id="B49-nutrients-11-01179"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>R.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Transfat involvement in cardiovascular disease</article-title><source>Mol. Nutr. Food Res.</source><year>2012</year><volume>56</volume><fpage>1090</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201100700</pub-id><?supplied-pmid 22760981?><pub-id pub-id-type="pmid">22760981</pub-id></element-citation></ref><ref id="B50-nutrients-11-01179"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebauer</surname><given-names>S.K.</given-names></name><name><surname>Chardigny</surname><given-names>J.M.</given-names></name><name><surname>Jakobsen</surname><given-names>M.U.</given-names></name><name><surname>Lamarche</surname><given-names>B.</given-names></name><name><surname>Lock</surname><given-names>A.L.</given-names></name><name><surname>Proctor</surname><given-names>S.D.</given-names></name><name><surname>Baer</surname><given-names>D.J.</given-names></name></person-group><article-title>Effects of ruminant trans fatty acids on cardiovascular disease and cancer: A comprehensive review of epidemiological, clinical, and mechanistic studies</article-title><source>Adv. Nutr.</source><year>2011</year><volume>2</volume><fpage>332</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.3945/an.111.000521</pub-id><pub-id pub-id-type="pmid">22332075</pub-id></element-citation></ref><ref id="B51-nutrients-11-01179"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Aro</surname><given-names>A.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name></person-group><article-title>Health effects of trans-fatty acids: Experimental and observational evidence</article-title><source>Eur. J. Clin. Nutr.</source><year>2009</year><volume>63</volume><issue>Suppl. 2</issue><fpage>S5</fpage><lpage>S21</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602973</pub-id></element-citation></ref><ref id="B52-nutrients-11-01179"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stampfer</surname><given-names>M.J.</given-names></name><name><surname>Sacks</surname><given-names>F.M.</given-names></name><name><surname>Salvini</surname><given-names>S.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Hennekens</surname><given-names>C.H.</given-names></name></person-group><article-title>A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction</article-title><source>N. Engl. J. Med.</source><year>1991</year><volume>325</volume><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1056/NEJM199108083250601</pub-id><pub-id pub-id-type="pmid">2062328</pub-id></element-citation></ref><ref id="B53-nutrients-11-01179"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mensink</surname><given-names>R.P.</given-names></name><name><surname>Zock</surname><given-names>P.L.</given-names></name><name><surname>Kester</surname><given-names>A.D.</given-names></name><name><surname>Katan</surname><given-names>M.B.</given-names></name></person-group><article-title>Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials</article-title><source>Am. J. Clin. Nutr.</source><year>2003</year><volume>77</volume><fpage>1146</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1093/ajcn/77.5.1146</pub-id><pub-id pub-id-type="pmid">12716665</pub-id></element-citation></ref><ref id="B54-nutrients-11-01179"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascherio</surname><given-names>A.</given-names></name><name><surname>Katan</surname><given-names>M.B.</given-names></name><name><surname>Zock</surname><given-names>P.L.</given-names></name><name><surname>Stampfer</surname><given-names>M.J.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name></person-group><article-title>Trans fatty acids and coronary heart disease</article-title><source>N. Engl. J. Med.</source><year>1999</year><volume>340</volume><fpage>1994</fpage><lpage>1998</lpage><pub-id pub-id-type="doi">10.1056/NEJM199906243402511</pub-id><pub-id pub-id-type="pmid">10379026</pub-id></element-citation></ref><ref id="B55-nutrients-11-01179"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Pischon</surname><given-names>T.</given-names></name><name><surname>Hankinson</surname><given-names>S.E.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Joshipura</surname><given-names>K.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name></person-group><article-title>Dietary intake of trans fatty acids and systemic inflammation in women</article-title><source>Am. J. Clin. Nutr.</source><year>2004</year><volume>79</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1093/ajcn/79.4.606</pub-id><pub-id pub-id-type="pmid">15051604</pub-id></element-citation></ref><ref id="B56-nutrients-11-01179"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P.</given-names></name><name><surname>Ridker</surname><given-names>P.M.</given-names></name><name><surname>Maseri</surname><given-names>A.</given-names></name></person-group><article-title>Inflammation and atherosclerosis</article-title><source>Circulation</source><year>2002</year><volume>105</volume><fpage>1135</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1161/hc0902.104353</pub-id><?supplied-pmid 11877368?><pub-id pub-id-type="pmid">11877368</pub-id></element-citation></ref><ref id="B57-nutrients-11-01179"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Garcia</surname><given-names>E.</given-names></name><name><surname>Schulze</surname><given-names>M.B.</given-names></name><name><surname>Meigs</surname><given-names>J.B.</given-names></name><name><surname>Manson</surname><given-names>J.E.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Stampfer</surname><given-names>M.J.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Hu</surname><given-names>F.B.</given-names></name></person-group><article-title>Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction</article-title><source>J. Nutr.</source><year>2005</year><volume>135</volume><fpage>562</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1093/jn/135.3.562</pub-id><?supplied-pmid 15735094?><pub-id pub-id-type="pmid">15735094</pub-id></element-citation></ref><ref id="B58-nutrients-11-01179"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virmani</surname><given-names>R.</given-names></name><name><surname>Kolodgie</surname><given-names>F.D.</given-names></name><name><surname>Burke</surname><given-names>A.P.</given-names></name><name><surname>Farb</surname><given-names>A.</given-names></name><name><surname>Schwartz</surname><given-names>S.M.</given-names></name></person-group><article-title>Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2000</year><volume>20</volume><fpage>1262</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.20.5.1262</pub-id><?supplied-pmid 10807742?><pub-id pub-id-type="pmid">10807742</pub-id></element-citation></ref><ref id="B59-nutrients-11-01179"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>A.P.</given-names></name><name><surname>Farb</surname><given-names>A.</given-names></name><name><surname>Malcom</surname><given-names>G.T.</given-names></name><name><surname>Liang</surname><given-names>Y.H.</given-names></name><name><surname>Smialek</surname><given-names>J.</given-names></name><name><surname>Virmani</surname><given-names>R.</given-names></name></person-group><article-title>Coronary risk factors and plaque morphology in men with coronary disease who died suddenly</article-title><source>N. Engl. J. Med.</source><year>1997</year><volume>336</volume><fpage>1276</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1056/NEJM199705013361802</pub-id><pub-id pub-id-type="pmid">9113930</pub-id></element-citation></ref><ref id="B60-nutrients-11-01179"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>Y.</given-names></name><name><surname>Shinke</surname><given-names>T.</given-names></name><name><surname>Toh</surname><given-names>R.</given-names></name><name><surname>Ishida</surname><given-names>T.</given-names></name><name><surname>Otake</surname><given-names>H.</given-names></name><name><surname>Takaya</surname><given-names>T.</given-names></name><name><surname>Sugiyama</surname><given-names>D.</given-names></name><name><surname>Toba</surname><given-names>T.</given-names></name><name><surname>Kuroda</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The impact of serum trans fatty acids concentration on plaque vulnerability in patients with coronary artery disease: Assessment via optical coherence tomography</article-title><source>Atherosclerosis</source><year>2017</year><volume>265</volume><fpage>312</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2017.06.922</pub-id><pub-id pub-id-type="pmid">28697847</pub-id></element-citation></ref><ref id="B61-nutrients-11-01179"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>A.H.</given-names></name></person-group><article-title>Dietary trans fatty acids and cardiovascular disease risk: Past and present</article-title><source>Curr. Atheroscler. Rep.</source><year>2014</year><volume>16</volume><fpage>433</fpage><pub-id pub-id-type="doi">10.1007/s11883-014-0433-1</pub-id><pub-id pub-id-type="pmid">24907053</pub-id></element-citation></ref><ref id="B62-nutrients-11-01179"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keys</surname><given-names>A.</given-names></name><name><surname>Menotti</surname><given-names>A.</given-names></name><name><surname>Aravanis</surname><given-names>C.</given-names></name><name><surname>Blackburn</surname><given-names>H.</given-names></name><name><surname>Djordevic</surname><given-names>B.S.</given-names></name><name><surname>Buzina</surname><given-names>R.</given-names></name><name><surname>Dontas</surname><given-names>A.S.</given-names></name><name><surname>Fidanza</surname><given-names>F.</given-names></name><name><surname>Karvonen</surname><given-names>M.J.</given-names></name><name><surname>Kimura</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The seven countries study: 2289 deaths in 15 years</article-title><source>Prev. Med.</source><year>1984</year><volume>13</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/0091-7435(84)90047-1</pub-id><pub-id pub-id-type="pmid">6739443</pub-id></element-citation></ref><ref id="B63-nutrients-11-01179"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehghan</surname><given-names>M.</given-names></name><name><surname>Mente</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Swaminathan</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Mohan</surname><given-names>V.</given-names></name><name><surname>Iqbal</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Wentzel-Viljoen</surname><given-names>E.</given-names></name><name><surname>Rosengren</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Prospective Urban Rural Epidemiology study. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study</article-title><source>Lancet</source><year>2017</year><volume>390</volume><fpage>2050</fpage><lpage>2062</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)32252-3</pub-id><pub-id pub-id-type="pmid">28864332</pub-id></element-citation></ref><ref id="B64-nutrients-11-01179"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyens</surname><given-names>P.L.</given-names></name><name><surname>Spilker</surname><given-names>M.E.</given-names></name><name><surname>Zock</surname><given-names>P.L.</given-names></name><name><surname>Katan</surname><given-names>M.B.</given-names></name><name><surname>Mensink</surname><given-names>R.P.</given-names></name></person-group><article-title>Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio</article-title><source>Am. J. Clin. Nutr.</source><year>2006</year><volume>84</volume><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1093/ajcn/84.1.44</pub-id><pub-id pub-id-type="pmid">16825680</pub-id></element-citation></ref><ref id="B65-nutrients-11-01179"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burdge</surname><given-names>G.C.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Dietary alpha-linolenic acid and health-related outcomes: A metabolic perspective</article-title><source>Nutr. Res. Rev.</source><year>2006</year><volume>19</volume><fpage>26</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1079/NRR2005113</pub-id><pub-id pub-id-type="pmid">19079874</pub-id></element-citation></ref><ref id="B66-nutrients-11-01179"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massiera</surname><given-names>F.</given-names></name><name><surname>Barbry</surname><given-names>P.</given-names></name><name><surname>Guesnet</surname><given-names>P.</given-names></name><name><surname>Joly</surname><given-names>A.</given-names></name><name><surname>Luquet</surname><given-names>S.</given-names></name><name><surname>Moreilhon-Brest</surname><given-names>C.</given-names></name><name><surname>Mohsen-Kanson</surname><given-names>T.</given-names></name><name><surname>Amri</surname><given-names>E.Z.</given-names></name><name><surname>Ailhaud</surname><given-names>G.</given-names></name></person-group><article-title>A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations</article-title><source>J. Lipid Res.</source><year>2006</year><volume>51</volume><fpage>2352</fpage><lpage>2361</lpage><pub-id pub-id-type="doi">10.1194/jlr.M006866</pub-id></element-citation></ref><ref id="B67-nutrients-11-01179"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivkovic</surname><given-names>A.M.</given-names></name><name><surname>Telis</surname><given-names>N.</given-names></name><name><surname>German</surname><given-names>J.B.</given-names></name><name><surname>Hammock</surname><given-names>B.D.</given-names></name></person-group><article-title>Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health</article-title><source>Calif. Agric. (Berkeley)</source><year>2011</year><volume>65</volume><fpage>106</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.3733/ca.v065n03p106</pub-id><pub-id pub-id-type="pmid">24860193</pub-id></element-citation></ref><ref id="B68-nutrients-11-01179"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricciotti</surname><given-names>E.</given-names></name><name><surname>FitzGerald</surname><given-names>G.A.</given-names></name></person-group><article-title>Prostaglandins and inflammation</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2011</year><volume>31</volume><fpage>986</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.207449</pub-id><pub-id pub-id-type="pmid">21508345</pub-id></element-citation></ref><ref id="B69-nutrients-11-01179"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Yuhki</surname><given-names>K.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Fujino</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>A.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Kuriyama</surname><given-names>S.</given-names></name><name><surname>Karibe</surname><given-names>H.</given-names></name><name><surname>Okada</surname><given-names>Y.</given-names></name><name><surname>Takahata</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia</article-title><source>Nat. Med.</source><year>2006</year><volume>11</volume><fpage>562</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1038/nm1231</pub-id></element-citation></ref><ref id="B70-nutrients-11-01179"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazarewicz</surname><given-names>R.R.</given-names></name><name><surname>Zenebe</surname><given-names>W.J.</given-names></name><name><surname>Parihar</surname><given-names>A.</given-names></name><name><surname>Parihar</surname><given-names>M.S.</given-names></name><name><surname>Vaccaro</surname><given-names>M.</given-names></name><name><surname>Rink</surname><given-names>C.</given-names></name><name><surname>Sen</surname><given-names>C.K.</given-names></name><name><surname>Ghafourifar</surname><given-names>P.</given-names></name></person-group><article-title>12(<italic>S</italic>)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium</article-title><source>Arch. Biochem. Biophys.</source><year>2007</year><volume>468</volume><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2007.09.018</pub-id><pub-id pub-id-type="pmid">17963719</pub-id></element-citation></ref><ref id="B71-nutrients-11-01179"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>D.W.</given-names></name><name><surname>Jaitly</surname><given-names>K.D.</given-names></name></person-group><article-title>Structure-activity relationships in a series of 11-deoxy prostaglandins</article-title><source>Prostaglandins</source><year>1976</year><volume>11</volume><fpage>573</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/0090-6980(76)90106-4</pub-id><pub-id pub-id-type="pmid">948628</pub-id></element-citation></ref><ref id="B72-nutrients-11-01179"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geoffroy</surname><given-names>J.</given-names></name><name><surname>Benzoni</surname><given-names>D.</given-names></name><name><surname>Sassard</surname><given-names>J.</given-names></name></person-group><article-title>Antihypertensive effect of thromboxane A2 receptor blockage in genetically hypertensive rats of the Lyon strain</article-title><source>J. Hypertens. Suppl.</source><year>1989</year><volume>7</volume><fpage>S272</fpage><lpage>S273</lpage><pub-id pub-id-type="doi">10.1097/00004872-198900076-00132</pub-id><pub-id pub-id-type="pmid">2534414</pub-id></element-citation></ref><ref id="B73-nutrients-11-01179"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>W.L.</given-names></name><name><surname>Urade</surname><given-names>Y.</given-names></name><name><surname>Jakobsson</surname><given-names>P.J.</given-names></name></person-group><article-title>Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis</article-title><source>Chem. Rev.</source><year>2011</year><volume>111</volume><fpage>5821</fpage><lpage>5865</lpage><pub-id pub-id-type="doi">10.1021/cr2002992</pub-id><pub-id pub-id-type="pmid">21942677</pub-id></element-citation></ref><ref id="B74-nutrients-11-01179"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hercule</surname><given-names>H.C.</given-names></name><name><surname>Schunck</surname><given-names>W.H.</given-names></name><name><surname>Gross</surname><given-names>V.</given-names></name><name><surname>Seringer</surname><given-names>J.</given-names></name><name><surname>Leung</surname><given-names>F.P.</given-names></name><name><surname>Weldon</surname><given-names>S.M.</given-names></name><name><surname>da Costa Goncalves</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Luft</surname><given-names>F.C.</given-names></name><name><surname>Gollasch</surname><given-names>M.</given-names></name></person-group><article-title>Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2009</year><volume>29</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.108.171298</pub-id><?supplied-pmid 18927469?><pub-id pub-id-type="pmid">18927469</pub-id></element-citation></ref><ref id="B75-nutrients-11-01179"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemaitre</surname><given-names>R.N.</given-names></name><name><surname>King</surname><given-names>I.B.</given-names></name><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Kuller</surname><given-names>L.H.</given-names></name><name><surname>Tracy</surname><given-names>R.P.</given-names></name><name><surname>Siscovick</surname><given-names>D.S.</given-names></name></person-group><article-title>n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study</article-title><source>Am. J. Clin. Nutr.</source><year>2003</year><volume>77</volume><fpage>319</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1093/ajcn/77.2.319</pub-id><pub-id pub-id-type="pmid">12540389</pub-id></element-citation></ref><ref id="B76-nutrients-11-01179"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Steering Committee of the Physicians&#x02019; Health Study Research Group</collab></person-group><article-title>Preliminary report: Findings from the aspirin component of the ongoing Physicians&#x02019; Health Study</article-title><source>N. Engl. J. Med.</source><year>1988</year><volume>318</volume><fpage>262</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1056/NEJM198801283180431</pub-id><?supplied-pmid 3275899?><pub-id pub-id-type="pmid">3275899</pub-id></element-citation></ref><ref id="B77-nutrients-11-01179"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tohgi</surname><given-names>H.</given-names></name><name><surname>Konno</surname><given-names>S.</given-names></name><name><surname>Tamura</surname><given-names>K.</given-names></name><name><surname>Kimura</surname><given-names>B.</given-names></name><name><surname>Kawano</surname><given-names>K.</given-names></name></person-group><article-title>Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin</article-title><source>Stroke</source><year>1992</year><volume>23</volume><fpage>1400</fpage><lpage>1403</lpage><pub-id pub-id-type="doi">10.1161/01.STR.23.10.1400</pub-id><pub-id pub-id-type="pmid">1412574</pub-id></element-citation></ref><ref id="B78-nutrients-11-01179"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Diemen</surname><given-names>J.J.</given-names></name><name><surname>Fuijkschot</surname><given-names>W.W.</given-names></name><name><surname>Wessels</surname><given-names>T.J.</given-names></name><name><surname>Veen</surname><given-names>G.</given-names></name><name><surname>Smulders</surname><given-names>Y.M.</given-names></name><name><surname>Thijs</surname><given-names>A.</given-names></name></person-group><article-title>Evening intake of aspirin is associated with a more stable 24-h platelet inhibition compared to morning intake: A study in chronic aspirin users</article-title><source>Platelets</source><year>2016</year><volume>27</volume><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.3109/09537104.2015.1107536</pub-id><?supplied-pmid 26599376?><pub-id pub-id-type="pmid">26599376</pub-id></element-citation></ref><ref id="B79-nutrients-11-01179"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randriamboavonjy</surname><given-names>V.</given-names></name><name><surname>Busse</surname><given-names>R.</given-names></name><name><surname>Fleming</surname><given-names>I.</given-names></name></person-group><article-title>20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase</article-title><source>Hypertension</source><year>2003</year><volume>41</volume><issue-part>Pt 2</issue-part><fpage>801</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000047240.33861.6B</pub-id><?supplied-pmid 12623999?><pub-id pub-id-type="pmid">12623999</pub-id></element-citation></ref><ref id="B80-nutrients-11-01179"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>M.A.</given-names></name><name><surname>Balazy</surname><given-names>M.</given-names></name><name><surname>Margiotta</surname><given-names>P.</given-names></name><name><surname>Huang</surname><given-names>D.D.</given-names></name><name><surname>Falck</surname><given-names>J.R.</given-names></name><name><surname>McGiff</surname><given-names>J.C.</given-names></name></person-group><article-title>Cytochrome P-450-dependent HETEs: Profile of biological activity and stimulation by vasoactive peptides</article-title><source>Am. J. Physiol.</source><year>2003</year><volume>271</volume><issue-part>Pt 2</issue-part><fpage>R863</fpage><lpage>R869</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.1996.271.4.R863</pub-id></element-citation></ref><ref id="B81-nutrients-11-01179"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>X.</given-names></name><name><surname>Faraci</surname><given-names>F.M.</given-names></name><name><surname>Kaduce</surname><given-names>T.L.</given-names></name><name><surname>Harmon</surname><given-names>S.</given-names></name><name><surname>Modrick</surname><given-names>M.L.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Moore</surname><given-names>S.A.</given-names></name><name><surname>Falck</surname><given-names>J.R.</given-names></name><name><surname>Weintraub</surname><given-names>N.L.</given-names></name><name><surname>Spector</surname><given-names>A.A.</given-names></name></person-group><article-title>20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: Role of cyclooxygenase</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2006</year><volume>291</volume><fpage>H2301</fpage><lpage>H2307</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00349.2006</pub-id><pub-id pub-id-type="pmid">16782846</pub-id></element-citation></ref><ref id="B82-nutrients-11-01179"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Back</surname><given-names>M.</given-names></name></person-group><article-title>Leukotriene signaling in atherosclerosis and ischemia</article-title><source>Cardiovasc. Drugs Ther.</source><year>2009</year><volume>23</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s10557-008-6140-9</pub-id><pub-id pub-id-type="pmid">18949546</pub-id></element-citation></ref><ref id="B83-nutrients-11-01179"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Yokoyama</surname><given-names>U.</given-names></name><name><surname>Fujita</surname><given-names>T.</given-names></name><name><surname>Okumura</surname><given-names>S.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name></person-group><article-title>The roles of cytochrome p450 in ischemic heart disease</article-title><source>Curr. Drug Metab.</source><year>2011</year><volume>12</volume><fpage>526</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.2174/138920011795713715</pub-id><?supplied-pmid 21476972?><pub-id pub-id-type="pmid">21476972</pub-id></element-citation></ref><ref id="B84-nutrients-11-01179"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>D.R.</given-names></name><name><surname>Zeldin</surname><given-names>D.C.</given-names></name><name><surname>Hoffman</surname><given-names>S.M.</given-names></name><name><surname>Maltais</surname><given-names>L.J.</given-names></name><name><surname>Wain</surname><given-names>H.M.</given-names></name><name><surname>Nebert</surname><given-names>D.W.</given-names></name></person-group><article-title>Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants</article-title><source>Pharmacogenetics</source><year>2004</year><volume>14</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1097/00008571-200401000-00001</pub-id><?supplied-pmid 15128046?><pub-id pub-id-type="pmid">15128046</pub-id></element-citation></ref><ref id="B85-nutrients-11-01179"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuchardt</surname><given-names>J.P.</given-names></name><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Kressel</surname><given-names>G.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Willenberg</surname><given-names>I.</given-names></name><name><surname>Hammock</surname><given-names>B.D.</given-names></name><name><surname>Hahn</surname><given-names>A.</given-names></name><name><surname>Schebb</surname><given-names>N.H.</given-names></name></person-group><article-title>Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men</article-title><source>Prostaglandins Leukot. Essent. Fatty Acids</source><year>2013</year><volume>89</volume><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.plefa.2013.04.001</pub-id><?supplied-pmid 23694766?><pub-id pub-id-type="pmid">23694766</pub-id></element-citation></ref><ref id="B86-nutrients-11-01179"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Murphy</surname><given-names>E.</given-names></name><name><surname>Gabel</surname><given-names>S.</given-names></name><name><surname>Tomer</surname><given-names>K.B.</given-names></name><name><surname>Foley</surname><given-names>J.</given-names></name><name><surname>Steenbergen</surname><given-names>C.</given-names></name><name><surname>Falck</surname><given-names>J.R.</given-names></name><name><surname>Moomaw</surname><given-names>C.R.</given-names></name><name><surname>Zeldin</surname><given-names>D.C.</given-names></name></person-group><article-title>Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>12551</fpage><lpage>12559</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.19.12551</pub-id><?supplied-pmid 9139707?><pub-id pub-id-type="pmid">9139707</pub-id></element-citation></ref><ref id="B87-nutrients-11-01179"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batchu</surname><given-names>S.N.</given-names></name><name><surname>Law</surname><given-names>E.</given-names></name><name><surname>Brocks</surname><given-names>D.R.</given-names></name><name><surname>Falck</surname><given-names>J.R.</given-names></name><name><surname>Seubert</surname><given-names>J.M.</given-names></name></person-group><article-title>Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model</article-title><source>J. Mol. Cell Cardiol.</source><year>2009</year><volume>46</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.09.711</pub-id><?supplied-pmid 18973759?><pub-id pub-id-type="pmid">18973759</pub-id></element-citation></ref><ref id="B88-nutrients-11-01179"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seubert</surname><given-names>J.M.</given-names></name><name><surname>Zeldin</surname><given-names>D.C.</given-names></name><name><surname>Nithipatikom</surname><given-names>K.</given-names></name><name><surname>Gross</surname><given-names>G.J.</given-names></name></person-group><article-title>Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury</article-title><source>Prostaglandins Lipid Mediat.</source><year>2007</year><volume>82</volume><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.prostaglandins.2006.05.017</pub-id><?supplied-pmid 17164132?><pub-id pub-id-type="pmid">17164132</pub-id></element-citation></ref><ref id="B89-nutrients-11-01179"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shureiqi</surname><given-names>I.</given-names></name><name><surname>Wojno</surname><given-names>K.J.</given-names></name><name><surname>Poore</surname><given-names>J.A.</given-names></name><name><surname>Reddy</surname><given-names>R.G.</given-names></name><name><surname>Moussalli</surname><given-names>M.J.</given-names></name><name><surname>Spindler</surname><given-names>S.A.</given-names></name><name><surname>Greenson</surname><given-names>J.K.</given-names></name><name><surname>Normolle</surname><given-names>D.</given-names></name><name><surname>Hasan</surname><given-names>A.A.</given-names></name><name><surname>Lawrence</surname><given-names>T.S.</given-names></name><etal/></person-group><article-title>Decreased 13-<italic>S</italic>-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers</article-title><source>Carcinogenesis</source><year>1999</year><volume>20</volume><fpage>1985</fpage><lpage>1995</lpage><pub-id pub-id-type="doi">10.1093/carcin/20.10.1985</pub-id><pub-id pub-id-type="pmid">10506115</pub-id></element-citation></ref><ref id="B90-nutrients-11-01179"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawcroft</surname><given-names>G.</given-names></name><name><surname>Loadman</surname><given-names>P.M.</given-names></name><name><surname>Belluzzi</surname><given-names>A.</given-names></name><name><surname>Hull</surname><given-names>M.A.</given-names></name></person-group><article-title>Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells</article-title><source>Neoplasia</source><year>2010</year><volume>12</volume><fpage>618</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1593/neo.10388</pub-id><pub-id pub-id-type="pmid">20689756</pub-id></element-citation></ref><ref id="B91-nutrients-11-01179"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>H.J.</given-names></name><name><surname>Stevens</surname><given-names>J.</given-names></name><name><surname>Grimminger</surname><given-names>F.</given-names></name><name><surname>Seeger</surname><given-names>W.</given-names></name></person-group><article-title>Fish oil fatty acids and human platelets: Dose-dependent decrease in dienoic and increase in trienoic thromboxane generation</article-title><source>Biochem. Pharmacol.</source><year>1996</year><volume>52</volume><fpage>1211</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(96)00473-X</pub-id><pub-id pub-id-type="pmid">8937428</pub-id></element-citation></ref><ref id="B92-nutrients-11-01179"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Needleman</surname><given-names>P.</given-names></name><name><surname>Raz</surname><given-names>A.</given-names></name><name><surname>Minkes</surname><given-names>M.S.</given-names></name><name><surname>Ferrendelli</surname><given-names>J.A.</given-names></name><name><surname>Sprecher</surname><given-names>H.</given-names></name></person-group><article-title>Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1979</year><volume>76</volume><fpage>944</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1073/pnas.76.2.944</pub-id><pub-id pub-id-type="pmid">218223</pub-id></element-citation></ref><ref id="B93-nutrients-11-01179"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>A.A.</given-names></name><name><surname>Deniset</surname><given-names>J.F.</given-names></name><name><surname>Austria</surname><given-names>J.A.</given-names></name><name><surname>LaVallee</surname><given-names>R.K.</given-names></name><name><surname>Maddaford</surname><given-names>G.G.</given-names></name><name><surname>Hedley</surname><given-names>T.E.</given-names></name><name><surname>Dibrov</surname><given-names>E.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Effects of dietary flaxseed on atherosclerotic plaque regression</article-title><source>Am. J. Physiol. Heart Circ. Physiol.</source><year>2013</year><volume>304</volume><fpage>H1743</fpage><lpage>H1751</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00606.2012</pub-id><pub-id pub-id-type="pmid">23585134</pub-id></element-citation></ref><ref id="B94-nutrients-11-01179"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westphal</surname><given-names>C.</given-names></name><name><surname>Konkel</surname><given-names>A.</given-names></name><name><surname>Schunck</surname><given-names>W.H.</given-names></name></person-group><article-title>CYP-eicosanoids&#x02014;A new link between omega-3 fatty acids and cardiac disease?</article-title><source>Prostaglandins Lipid Mediat.</source><year>2011</year><volume>96</volume><fpage>99</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.prostaglandins.2011.09.001</pub-id><?supplied-pmid 21945326?><pub-id pub-id-type="pmid">21945326</pub-id></element-citation></ref><ref id="B95-nutrients-11-01179"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Koh</surname><given-names>H.W.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Koh</surname><given-names>W.P.</given-names></name><name><surname>Yuan</surname><given-names>J.M.</given-names></name><name><surname>Newman</surname><given-names>J.W.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Ong</surname><given-names>C.N.</given-names></name><name><surname>van Dam</surname><given-names>R.M.</given-names></name></person-group><article-title>Plasma fatty acids, oxylipins, and risk of myocardial infarction: The Singapore Chinese Health Study</article-title><source>J. Lipid Res.</source><year>2016</year><volume>57</volume><fpage>1300</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1194/jlr.P066423</pub-id><?supplied-pmid 27371261?><pub-id pub-id-type="pmid">27371261</pub-id></element-citation></ref><ref id="B96-nutrients-11-01179"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botham</surname><given-names>K.M.</given-names></name><name><surname>Bravo</surname><given-names>E.</given-names></name><name><surname>Elliott</surname><given-names>J.</given-names></name><name><surname>Wheeler-Jones</surname><given-names>C.P.</given-names></name></person-group><article-title>Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: Implications for atherosclerosis development</article-title><source>Curr. Pharm. Des.</source><year>2005</year><volume>11</volume><fpage>3681</fpage><lpage>3695</lpage><pub-id pub-id-type="doi">10.2174/138161205774580732</pub-id><?supplied-pmid 16305504?><pub-id pub-id-type="pmid">16305504</pub-id></element-citation></ref><ref id="B97-nutrients-11-01179"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>K.C.</given-names></name><name><surname>Mamo</surname><given-names>J.C.</given-names></name></person-group><article-title>Chylomicron-remnant-induced foam cell formation and cytotoxicity: A possible mechanism of cell death in atherosclerosis</article-title><source>Clin. Sci. (Lond.)</source><year>2000</year><volume>98</volume><fpage>183</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1042/cs0980183</pub-id><pub-id pub-id-type="pmid">10657274</pub-id></element-citation></ref><ref id="B98-nutrients-11-01179"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Pascale</surname><given-names>C.</given-names></name><name><surname>Avella</surname><given-names>M.</given-names></name><name><surname>Perona</surname><given-names>J.S.</given-names></name><name><surname>Ruiz-Gutierrez</surname><given-names>V.</given-names></name><name><surname>Wheeler-Jones</surname><given-names>C.P.</given-names></name><name><surname>Botham</surname><given-names>K.M.</given-names></name></person-group><article-title>Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages</article-title><source>FEBS J.</source><year>2006</year><volume>273</volume><fpage>5632</fpage><lpage>5640</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2006.05552.x</pub-id><?supplied-pmid 17096688?><pub-id pub-id-type="pmid">17096688</pub-id></element-citation></ref><ref id="B99-nutrients-11-01179"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Caterina</surname><given-names>R.</given-names></name><name><surname>Madonna</surname><given-names>R.</given-names></name><name><surname>Massaro</surname><given-names>M.</given-names></name></person-group><article-title>Effects of omega-3 fatty acids on cytokines and adhesion molecules</article-title><source>Curr. Atheroscler. Rep.</source><year>2004</year><volume>6</volume><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1007/s11883-004-0090-x</pub-id><pub-id pub-id-type="pmid">15485595</pub-id></element-citation></ref><ref id="B100-nutrients-11-01179"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thies</surname><given-names>F.</given-names></name><name><surname>Garry</surname><given-names>J.M.</given-names></name><name><surname>Yaqoob</surname><given-names>P.</given-names></name><name><surname>Rerkasem</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>J.</given-names></name><name><surname>Shearman</surname><given-names>C.P.</given-names></name><name><surname>Gallagher</surname><given-names>P.J.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name><name><surname>Grimble</surname><given-names>R.F.</given-names></name></person-group><article-title>Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomized controlled trial</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>477</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)12468-3</pub-id><pub-id pub-id-type="pmid">12583947</pub-id></element-citation></ref><ref id="B101-nutrients-11-01179"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name></person-group><article-title>Metabolic Modulators in Heart Disease: Past, Present, and Future</article-title><source>Can. J. Cardiol.</source><year>2017</year><volume>33</volume><fpage>838</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2016.12.013</pub-id><pub-id pub-id-type="pmid">28279520</pub-id></element-citation></ref><ref id="B102-nutrients-11-01179"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochachka</surname><given-names>P.W.</given-names></name><name><surname>Mommsen</surname><given-names>T.P.</given-names></name></person-group><article-title>Protons and anaerobiosis</article-title><source>Science</source><year>1983</year><volume>219</volume><fpage>1391</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.1126/science.6298937</pub-id><pub-id pub-id-type="pmid">6298937</pub-id></element-citation></ref><ref id="B103-nutrients-11-01179"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Clanachan</surname><given-names>A.S.</given-names></name><name><surname>Schulz</surname><given-names>R.</given-names></name><name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name></person-group><article-title>Cardiac efficiency is improved after ischemia by altering both the source and fate of protons</article-title><source>Circ. Res.</source><year>1996</year><volume>79</volume><fpage>940</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1161/01.RES.79.5.940</pub-id><pub-id pub-id-type="pmid">8888686</pub-id></element-citation></ref><ref id="B104-nutrients-11-01179"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name><name><surname>Barr</surname><given-names>R.</given-names></name><name><surname>Thomas</surname><given-names>P.D.</given-names></name><name><surname>Dyck</surname><given-names>J.R.</given-names></name></person-group><article-title>Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase</article-title><source>Circ. Res.</source><year>2003</year><volume>93</volume><fpage>e33</fpage><lpage>e37</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000086964.07404.A5</pub-id><pub-id pub-id-type="pmid">12869392</pub-id></element-citation></ref><ref id="B105-nutrients-11-01179"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>R.</given-names></name><name><surname>Hasanally</surname><given-names>D.</given-names></name><name><surname>Stamenkovic</surname><given-names>A.</given-names></name><name><surname>Maddaford</surname><given-names>T.G.</given-names></name><name><surname>Chaudhary</surname><given-names>R.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name><name><surname>Ravandi</surname><given-names>A.</given-names></name></person-group><article-title>Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion</article-title><source>Mol. Cell. Biochem.</source><year>2018</year><volume>437</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1007/s11010-017-3104-z</pub-id><pub-id pub-id-type="pmid">28634855</pub-id></element-citation></ref><ref id="B106-nutrients-11-01179"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>C.W.</given-names></name><name><surname>Hasanally</surname><given-names>D.</given-names></name><name><surname>Mundt</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xiang</surname><given-names>B.</given-names></name><name><surname>Klein</surname><given-names>J.</given-names></name><name><surname>Muller</surname><given-names>A.</given-names></name><name><surname>Ambrose</surname><given-names>E.</given-names></name><name><surname>Ravandi</surname><given-names>A.</given-names></name><name><surname>Arora</surname><given-names>R.C.</given-names></name><etal/></person-group><article-title>A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion</article-title><source>J. Heart Lung Transplant.</source><year>2015</year><volume>34</volume><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.healun.2014.09.021</pub-id><?supplied-pmid 25447577?><pub-id pub-id-type="pmid">25447577</pub-id></element-citation></ref><ref id="B107-nutrients-11-01179"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeang</surname><given-names>C.</given-names></name><name><surname>Hasanally</surname><given-names>D.</given-names></name><name><surname>Que</surname><given-names>X.</given-names></name><name><surname>Hung</surname><given-names>M.Y.</given-names></name><name><surname>Stamenkovic</surname><given-names>A.</given-names></name><name><surname>Chan</surname><given-names>D.</given-names></name><name><surname>Chaudhary</surname><given-names>R.</given-names></name><name><surname>Margulets</surname><given-names>V.</given-names></name><name><surname>Edel</surname><given-names>A.L.</given-names></name><name><surname>Hoshijima</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Reduction of myocardial ischemia-reperfusion injury by inactivating oxidized phospholipids</article-title><source>Cardiovasc. Res.</source><year>2019</year><volume>115</volume><fpage>179</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvy136</pub-id><pub-id pub-id-type="pmid">29850765</pub-id></element-citation></ref><ref id="B108-nutrients-11-01179"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lorgeril</surname><given-names>M.</given-names></name><name><surname>Salen</surname><given-names>P.</given-names></name><name><surname>Martin</surname><given-names>J.L.</given-names></name><name><surname>Monjaud</surname><given-names>I.</given-names></name><name><surname>Delaye</surname><given-names>J.</given-names></name><name><surname>Mamelle</surname><given-names>N.</given-names></name></person-group><article-title>Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study</article-title><source>Circulation</source><year>1999</year><volume>99</volume><fpage>779</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.99.6.779</pub-id><?supplied-pmid 9989963?><pub-id pub-id-type="pmid">9989963</pub-id></element-citation></ref><ref id="B109-nutrients-11-01179"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celis-Morales</surname><given-names>C.A.</given-names></name><name><surname>Lyall</surname><given-names>D.M.</given-names></name><name><surname>Gray</surname><given-names>S.R.</given-names></name><name><surname>Steell</surname><given-names>L.</given-names></name><name><surname>Anderson</surname><given-names>J.</given-names></name><name><surname>Iliodromiti</surname><given-names>S.</given-names></name><name><surname>Welsh</surname><given-names>P.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Petermann</surname><given-names>F.</given-names></name><name><surname>Mackay</surname><given-names>D.F.</given-names></name><etal/></person-group><article-title>Dietary fat and total energy intake modifies the association of genetic profile risk score on obesity: Evidence from 48 170 UK Biobank participants</article-title><source>Int. J. Obes. (Lond.)</source><year>2017</year><volume>41</volume><fpage>1761</fpage><lpage>1768</lpage><pub-id pub-id-type="doi">10.1038/ijo.2017.169</pub-id><?supplied-pmid 28736445?><pub-id pub-id-type="pmid">28736445</pub-id></element-citation></ref><ref id="B110-nutrients-11-01179"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorente-Cebrian</surname><given-names>S.</given-names></name><name><surname>Costa</surname><given-names>A.G.</given-names></name><name><surname>Navas-Carretero</surname><given-names>S.</given-names></name><name><surname>Zabala</surname><given-names>M.</given-names></name><name><surname>Martinez</surname><given-names>J.A.</given-names></name><name><surname>Moreno-Aliaga</surname><given-names>M.J.</given-names></name></person-group><article-title>Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: A review of the evidence</article-title><source>J. Physiol. Biochem.</source><year>2013</year><volume>69</volume><fpage>633</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1007/s13105-013-0265-4</pub-id><?supplied-pmid 23794360?><pub-id pub-id-type="pmid">23794360</pub-id></element-citation></ref><ref id="B111-nutrients-11-01179"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>M.</given-names></name><name><surname>Mirzaei</surname><given-names>F.</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>E.J.</given-names></name><name><surname>Pan</surname><given-names>A.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Kawachi</surname><given-names>I.</given-names></name><name><surname>Koenen</surname><given-names>K.</given-names></name><name><surname>Ascherio</surname><given-names>A.</given-names></name></person-group><article-title>Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: A 10-y prospective follow-up study</article-title><source>Am. J. Clin. Nutr.</source><year>2011</year><volume>93</volume><fpage>1337</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.3945/ajcn.111.011817</pub-id><pub-id pub-id-type="pmid">21471279</pub-id></element-citation></ref><ref id="B112-nutrients-11-01179"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javadi</surname><given-names>M.</given-names></name><name><surname>Geelen</surname><given-names>M.J.</given-names></name><name><surname>Everts</surname><given-names>H.</given-names></name><name><surname>Hovenier</surname><given-names>R.</given-names></name><name><surname>Javadi</surname><given-names>S.</given-names></name><name><surname>Kappert</surname><given-names>H.</given-names></name><name><surname>Beynen</surname><given-names>A.C.</given-names></name></person-group><article-title>Effect of dietary conjugated linoleic acid on body composition and energy balance in broiler chickens</article-title><source>Br. J. Nutr.</source><year>2007</year><volume>98</volume><fpage>1152</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1017/S0007114507772677</pub-id><?supplied-pmid 17559699?><pub-id pub-id-type="pmid">17559699</pub-id></element-citation></ref><ref id="B113-nutrients-11-01179"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhlhausler</surname><given-names>B.S.</given-names></name><name><surname>Ailhaud</surname><given-names>G.P.</given-names></name></person-group><article-title>Omega-6 polyunsaturated fatty acids and the early origins of obesity</article-title><source>Curr. Opin. Endocrinol. Diabetes Obes.</source><year>2013</year><volume>20</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1097/MED.0b013e32835c1ba7</pub-id><pub-id pub-id-type="pmid">23249760</pub-id></element-citation></ref><ref id="B114-nutrients-11-01179"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Keung</surname><given-names>W.</given-names></name><name><surname>Samokhvalov</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Lopaschuk</surname><given-names>G.D.</given-names></name></person-group><article-title>Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle</article-title><source>Biochim. Biophys. Acta</source><year>2010</year><volume>1801</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2009.09.014</pub-id><pub-id pub-id-type="pmid">19782765</pub-id></element-citation></ref><ref id="B115-nutrients-11-01179"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwenk</surname><given-names>R.W.</given-names></name><name><surname>Luiken</surname><given-names>J.J.</given-names></name><name><surname>Bonen</surname><given-names>A.</given-names></name><name><surname>Glatz</surname><given-names>J.F.</given-names></name></person-group><article-title>Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease</article-title><source>Cardiovasc. Res.</source><year>2008</year><volume>79</volume><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvn116</pub-id><?supplied-pmid 18469026?><pub-id pub-id-type="pmid">18469026</pub-id></element-citation></ref><ref id="B116-nutrients-11-01179"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonen</surname><given-names>A.</given-names></name><name><surname>Campbell</surname><given-names>S.E.</given-names></name><name><surname>Benton</surname><given-names>C.R.</given-names></name><name><surname>Chabowski</surname><given-names>A.</given-names></name><name><surname>Coort</surname><given-names>S.L.</given-names></name><name><surname>Han</surname><given-names>X.X.</given-names></name><name><surname>Koonen</surname><given-names>D.P.</given-names></name><name><surname>Glatz</surname><given-names>J.F.</given-names></name><name><surname>Luiken</surname><given-names>J.J.</given-names></name></person-group><article-title>Regulation of fatty acid transport by fatty acid translocase/CD36</article-title><source>Proc. Nutr. Soc.</source><year>2004</year><volume>63</volume><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1079/PNS2004331</pub-id><pub-id pub-id-type="pmid">15294038</pub-id></element-citation></ref><ref id="B117-nutrients-11-01179"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>P.C.</given-names></name><name><surname>Drosatos</surname><given-names>K.</given-names></name><name><surname>Goldberg</surname><given-names>I.J.</given-names></name></person-group><article-title>Lipid Use and Misuse by the Heart</article-title><source>Circ. Res.</source><year>2016</year><volume>118</volume><fpage>1736</fpage><lpage>1751</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.306842</pub-id><?supplied-pmid 27230639?><pub-id pub-id-type="pmid">27230639</pub-id></element-citation></ref><ref id="B118-nutrients-11-01179"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahey</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Carley</surname><given-names>A.N.</given-names></name><name><surname>Lewandowski</surname><given-names>E.D.</given-names></name></person-group><article-title>Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride</article-title><source>Circulation</source><year>2014</year><volume>130</volume><fpage>1790</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.011687</pub-id><?supplied-pmid 25266948?><pub-id pub-id-type="pmid">25266948</pub-id></element-citation></ref><ref id="B119-nutrients-11-01179"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehto</surname><given-names>H.R.</given-names></name><name><surname>Parkka</surname><given-names>J.</given-names></name><name><surname>Borra</surname><given-names>R.</given-names></name><name><surname>Tuunanen</surname><given-names>H.</given-names></name><name><surname>Lepomaki</surname><given-names>V.</given-names></name><name><surname>Parkkola</surname><given-names>R.</given-names></name><name><surname>Knuuti</surname><given-names>J.</given-names></name><name><surname>Nuutila</surname><given-names>P.</given-names></name><name><surname>Iozzo</surname><given-names>P.</given-names></name></person-group><article-title>Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2012</year><volume>97</volume><fpage>3277</fpage><lpage>3284</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-1219</pub-id><pub-id pub-id-type="pmid">22761459</pub-id></element-citation></ref><ref id="B120-nutrients-11-01179"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>P.</given-names></name><name><surname>Winhofer</surname><given-names>Y.</given-names></name><name><surname>Krssak</surname><given-names>M.</given-names></name><name><surname>Smajis</surname><given-names>S.</given-names></name><name><surname>Harreiter</surname><given-names>J.</given-names></name><name><surname>Kosi-Trebotic</surname><given-names>L.</given-names></name><name><surname>Furnsinn</surname><given-names>C.</given-names></name><name><surname>Anderwald</surname><given-names>C.H.</given-names></name><name><surname>Baumgartner-Parzer</surname><given-names>S.</given-names></name><name><surname>Trattnig</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2016</year><volume>26</volume><fpage>387</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2016.03.012</pub-id><pub-id pub-id-type="pmid">27118107</pub-id></element-citation></ref></ref-list></back></article>